{"content":"<li class=\"n-box-item date-title\" data-end=\"1495166399\" data-start=\"1495080000\" data-txt=\"Monday, December 23, 2019\">Thursday, May 18, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3268677\" data-ts=\"1495149399\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLOB\" target=\"_blank\">GLOB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268677-globantminus-2_5-after-low-side-profit-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Globant -2.5% after low-side profit guidance</a></h4><ul>   <li>Tech services firm Globant (<a href=\"http://seekingalpha.com/symbol/GLOB\" target=\"_blank\">GLOB</a> <font color='red'>-1.3%</font>) is <font color='red'>2.5% lower</font> after hours following the release of <a href=\"https://seekingalpha.com/news/3268616-globant-eps-line-beats-revenue\" target=\"_blank\">Q1 earnings</a> where record revenue beat expectations, but profit guidance lagged the Street.</li>    <li>Revenues were up 21%, and gross profit increased 4.8% to $34.6M. Net income rose 15.7% to $9.7M.</li>    <li>At quarter's end, it had 5,855 \"Globers\"; 5,421 of those were IT pros. Globant's top customer made up 9.7% of revenues; its top 5, 31.1% of revenues; and its top 10, 43.7% of revenues.</li>    <li>Cash and equivalents and investments fell to $41.2M from year-end 2016's $59.9M.</li>    <li>For Q2, it's guiding to revenue of $95M-$97M (in line) and non-IFRS EPS of $0.26-$0.28, below consensus for $0.33. For the full year, it sees revenue of $386M-$394M (in line) and non-IFRS EPS of $1.22-$1.30, below an expected $1.35.</li>    <li><a href=\"https://seekingalpha.com/pr/16838213-globant-reports-2017-first-quarter-financial-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3268677\" data-linked=\"Globant -2.5% after low-side profit guidance\" data-tweet=\"$GLOB - Globant -2.5% after low-side profit guidance https://seekingalpha.com/news/3268677-globantminus-2_5-after-low-side-profit-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3268677-globantminus-2_5-after-low-side-profit-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268676\" data-ts=\"1495149052\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPS\" target=\"_blank\">GPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268676-gapplus-4_5-old-navy-leads-surprise-rise-in-store-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gap +4.5% as Old Navy leads surprise rise in same-store sales</a></h4><ul>     <li>Gap (NYSE:<a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a>)&nbsp;<font color='green'>+4.5%</font>&nbsp;AH after reporting an easy <a href=\"https://seekingalpha.com/news/3268629-gap-beats-0_07-beats-revenue\" target=\"_blank\">Q1 earnings</a> beat and a surprise rise in quarterly same-store sales, the latest indication that the company is <a href=\"http://www.reuters.com/article/us-gap-results-idUSKCN18E302\" target=\"_blank\">gaining from its turnaround  plan</a>.</li>     <li>Gap says Q1 comparable sales rose 2% Y/Y vs. flat estimates and a 5% decrease a year ago; Old Navy comp sales rose 8% vs. a 6% drop last year, Gap brand comp sales fell 4% vs. a 35 decline last year, and Banana Republic comp sales fell 4% vs. an 11% drop last year.</li>     <li>Gap reaffirms FY 2018 EPS guidance of  $1.95-$2.05 vs. $1.99 analyst consensus estimate, and continues to expect 2017 comparable sales to be flat to up slightly; the company has been reining in costs, shuttering underperforming stores and building up its e-commerce capacity.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3268676\" data-linked=\"Gap +4.5% as Old Navy leads surprise rise in same-store sales\" data-tweet=\"$GPS - Gap +4.5% as Old Navy leads surprise rise in same-store sales https://seekingalpha.com/news/3268676-gapplus-4_5-old-navy-leads-surprise-rise-in-store-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/3268676-gapplus-4_5-old-navy-leads-surprise-rise-in-store-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268674\" data-ts=\"1495147590\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTDOY\" target=\"_blank\">NTDOY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268674-switch-helps-pace-second-straight-month-of-videogame-sales-increases\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Switch helps pace second straight month of videogame sales increases</a></h4><ul>   <li>Videogame sales grew for the second straight month -- the first time that's happened since November 2015.</li>    <li>Overall sales increased 10%, to $636M, the second straight increase after nine straight Y/Y declines, according to NPD Group. Hardware sales again led the way, up 37% to $195M, thanks to the Nintendo Switch (<a href=\"http://seekingalpha.com/symbol/NTDOY\" target=\"_blank\">NTDOY</a> <font color='green'>+1.8%</font>).</li>    <li>Switch sales exceeded 280,000 units. Accessories grew 4% to $126M, again with help of sales of the Nintendo Switch Pro controller.</li>    <li>On the software side, videogame software increased 6% to $304M, while PC game software (physical and via Steam) fell 57% to $11M. Cross-platform, videogame sales got a boost from chart-topping debuts form <i>Mario Kart 8</i> (<a href='https://seekingalpha.com/symbol/NTDOY' title='Nintendo Co., Ltd. ADR'>OTCPK:NTDOY</a>) and <i>Persona 5</i> (Atlus).</li>    <li>Rounding out the dollar sales chart for software: No. 3, <i>The Legend of Zelda, Breath of the Wild</i> (<a href='https://seekingalpha.com/symbol/NTDOY' title='Nintendo Co., Ltd. ADR'>OTCPK:NTDOY</a>); No. 4, <i>MLB 17: The Show</i> (<a href=\"http://seekingalpha.com/symbol/SNE\" target=\"_blank\">SNE</a> <font color='red'>-0.1%</font>); No. 5, <i>Tom Clancy's Ghost Recon: Wildlands</i> (<a href=\"http://seekingalpha.com/symbol/UBSFY\" target=\"_blank\">UBSFY</a> <font color='green'>+0.3%</font>); No. 6, <i>Grand Theft Auto V</i> (<a href=\"http://seekingalpha.com/symbol/TTWO\" target=\"_blank\">TTWO</a> <font color='green'>+3.1%</font>); No. 7, <i>Mass Effect: Andromeda</i> (<a href=\"http://seekingalpha.com/symbol/EA\" target=\"_blank\">EA</a> <font color='green'>+1.6%</font>); No. 8, <i>NBA 2K17</i> (NASDAQ:<a href='https://seekingalpha.com/symbol/TTWO' title='Take-Two Interactive Software, Inc.'>TTWO</a>); No. 9, <i>Overwatch</i> (<a href=\"http://seekingalpha.com/symbol/ATVI\" target=\"_blank\">ATVI</a> <font color='green'>+1.7%</font>); No. 10, <i>Call of Duty: Black Ops II</i> (NASDAQ:<a href='https://seekingalpha.com/symbol/ATVI' title='Activision Blizzard, Inc'>ATVI</a>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3268674\" data-linked=\"Switch helps pace second straight month of videogame sales increases\" data-tweet=\"$NTDOY $NTDOY $TTWO - Switch helps pace second straight month of videogame sales increases https://seekingalpha.com/news/3268674-switch-helps-pace-second-straight-month-of-videogame-sales-increases?source=tweet\" data-url=\"https://seekingalpha.com/news/3268674-switch-helps-pace-second-straight-month-of-videogame-sales-increases\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268670\" data-ts=\"1495144962\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTXP\" target=\"_blank\">PTXP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268670-energy-transfer-partners-makes-20-unit-tender-offer-for-penntex-midstream\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy Transfer Partners makes $20/unit tender offer for PennTex Midstream</a></h4><ul>     <li>PennTex Midstream Partners (NASDAQ:<a href='https://seekingalpha.com/symbol/PTXP' title='PennTex Midstream Partners'>PTXP</a>) <font color='green'>+19.3%</font>&nbsp;AH after Energy Transfer Partners (ETP) makes a <a href=\"https://seekingalpha.com/pr/16838327-energy-transfer-partners-l-p-announces-tender-offer-purchase-common-units-penntex-midstream\" target=\"_blank\">tender offer</a> to purchase all common units it does not already own for $20/unit in cash.</li><li>ETP currently owns 32.4% of outstanding PTXP common units; the tender offer will expire on June 19.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3268670\" data-linked=\"Energy Transfer Partners makes $20/unit tender offer for PennTex Midstream\" data-tweet=\"$PTXP $PTXP $ET - Energy Transfer Partners makes $20/unit tender offer for PennTex Midstream https://seekingalpha.com/news/3268670-energy-transfer-partners-makes-20-unit-tender-offer-for-penntex-midstream?source=tweet\" data-url=\"https://seekingalpha.com/news/3268670-energy-transfer-partners-makes-20-unit-tender-offer-for-penntex-midstream\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>77&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268664\" data-ts=\"1495143364\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268664-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/SPWH' title='Sportsman&#39;s Warehouse Holdings, Inc.'>SPWH</a> <font color='green'>+13.1%</font>. <a href='https://seekingalpha.com/symbol/ADSK' title='Autodesk, Inc.'>ADSK</a> <font color='green'>+10.5%</font>. <a href='https://seekingalpha.com/symbol/MCK' title='McKesson Corporation'>MCK</a> <font color='green'>+9.3%</font>. <a href='https://seekingalpha.com/symbol/SB' title='Safe Bulkers Inc.'>SB</a> <font color='green'>+8.2%</font>. <a href='https://seekingalpha.com/symbol/SN' title='Sanchez Energy Corporation'>SN</a> <font color='green'>+5.0%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/HALO' title='Halozyme Therapeutics, Inc.'>HALO</a> <font color='red'>-7.4%</font>. <a href='https://seekingalpha.com/symbol/HZNP' title='Horizon Pharma plc'>HZNP</a> <font color='red'>-4.0%</font>. <a href='https://seekingalpha.com/symbol/GSBD' title='Goldman Sachs BDC'>GSBD</a> <font color='red'>-2.9%</font>. <a href='https://seekingalpha.com/symbol/RSPP' title='RSP Permian'>RSPP</a> <font color='red'>-2.9%</font>. <a href='https://seekingalpha.com/symbol/GLOB' title='Globant'>GLOB</a> <font color='red'>-2.5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3268664\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$SPWH $ADSK $MCK - After Hours Gainers / Losers https://seekingalpha.com/news/3268664-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3268664-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268647\" data-ts=\"1495140556\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMAT\" target=\"_blank\">AMAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268647-applied-materialsplus-3_3-after-record-revenues-profits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Applied Materials +3.3% after record revenues, profits</a></h4><ul>   <li>Applied Materials (<a href=\"http://seekingalpha.com/symbol/AMAT\" target=\"_blank\">AMAT</a> <font color='green'>+2.7%</font>) has turned up in after-hours trade, <font color='green'>+3.3%</font>, after posting <a href=\"https://seekingalpha.com/news/3268601-applied-materials-beats-0_03-beats-revenue\" target=\"_blank\">Q2 earnings</a> with record revenues and its fourth straight quarter of record profits.</li>    <li>EPS more than doubled on a non-GAAP basis to $0.79. Gross margin was up by 3.6 points, to 46.3% (non-GAAP), and operating margin was up 8.6 points to 27.8%.</li>    <li>Cash from operations came to $898M.</li>    <li>Revenue by segment: Semiconductor systems, $2.4B (up 51.5%); Applied Global Services, $724M (up 14.4%); Display and Adjacent Markets, $391M (up 109.1%).</li>    <li>Revenue mix in semiconductor systems: Foundry, 41% (vs. year-ago 30%); DRAM, 19% (vs. year-ago 20%); Flash, 33% (vs. year-ago 42%); Logic and other, 7% (vs. year-ago 8%).</li>    <li>For Q3, it's guiding to net sales of $3.6B-$3.75B (up 30% at the midpoint, and above consensus for $3.43B), and non-GAAP EPS of $0.79-$0.87 (up 66% at the midpoint, and above consensus for $0.69).</li>    <li><a href=\"https://seekingalpha.com/pr/16838167-applied-materials-delivers-record-revenue-earnings-per-share\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3268647\" data-linked=\"Applied Materials +3.3% after record revenues, profits\" data-tweet=\"$AMAT - Applied Materials +3.3% after record revenues, profits https://seekingalpha.com/news/3268647-applied-materialsplus-3_3-after-record-revenues-profits?source=tweet\" data-url=\"https://seekingalpha.com/news/3268647-applied-materialsplus-3_3-after-record-revenues-profits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268638\" data-ts=\"1495139414\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCK\" target=\"_blank\">MCK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268638-mckesson-fq4-top-line-up-4-earnings-up-733-cash-flow-up-29-shares-up-6-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">McKesson FQ4 top line up 4%, earnings up 733%; cash flow up 29%; shares up 6% after hours</a></h4><ul><li>McKesson (NYSE:<a href='https://seekingalpha.com/symbol/MCK' title='McKesson Corporation'>MCK</a>) <a href=\"https://seekingalpha.com/pr/16838217-mckesson-reports-fiscal-2017-fourth-quarter-full-year-results\" target=\"_blank\">fiscal Q4 results</a> ($M): Revenues: 48,713 (+4.4%); Net Income: 3,588 (+732.5%); EPS: 16.76 (+791.5%); CF Ops: 4,744 (+29.2%).</li><li><strong>Fiscal 2018 guidance</strong>: North America pharmaceutical distribution &amp; services revenue growth: mid-single digit; EPS: $7.10 - 8.80; Non-GAAP EPS: $11.75 - 12.45; cash flow ops growth: -10%.</li><li>Shares are up&nbsp;<font color='green'>6%</font>&nbsp;after hours on modestly higher volume.</li><li>Competitors Cardinal Health (NYSE:<a href='https://seekingalpha.com/symbol/CAH' title='Cardinal Health Inc.'>CAH</a>) and AmerisourceBergen (NYSE:<a href='https://seekingalpha.com/symbol/ABC' title='AmerisourceBergen Corporation'>ABC</a>) are both up&nbsp;<font color='green'>2%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3268638\" data-linked=\"McKesson FQ4 top line up 4%, earnings up 733%; cash flow up 29%; shares up 6% after hours\" data-tweet=\"$MCK $MCK $CAH - McKesson FQ4 top line up 4%, earnings up 733%; cash flow up 29%; shares up 6% after hours https://seekingalpha.com/news/3268638-mckesson-fq4-top-line-up-4-earnings-up-733-cash-flow-up-29-shares-up-6-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3268638-mckesson-fq4-top-line-up-4-earnings-up-733-cash-flow-up-29-shares-up-6-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268635\" data-ts=\"1495139094\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RSPP\" target=\"_blank\">RSPP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268635-rsp-permian-to-launch-15m-share-secondary-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RSP Permian to launch 15M-share secondary offering</a></h4><ul><li>RSP&nbsp;Permian (NYSE:<a href='https://seekingalpha.com/symbol/RSPP' title='RSP Permian'>RSPP</a>) <font color='red'>-2.9%</font>&nbsp;AH after announcing a <a href=\"https://seekingalpha.com/pr/16838212-rsp-permian-inc-announces-secondary-public-offering-common-stock\" target=\"_blank\">public offering</a> of 15M common shares by Silver Hill Energy Partners Holdings, with an underwriters option to purchase up to an additional 2.25M shares; RSPP will receive no proceeds from the offering.</li><li>RSP Permian also <a href=\"https://www.streetinsider.com/SEC+Filings/Form+S-3ASR+RSP+Permian%2C+Inc.+/12923474.html\" target=\"_blank\">files</a> for an offering of nearly 27.9M common shares by selling shareholders.</li></ul><div class=\"tiny-share-widget\" data-id=\"3268635\" data-linked=\"RSP Permian to launch 15M-share secondary offering\" data-tweet=\"$RSPP - RSP Permian to launch 15M-share secondary offering https://seekingalpha.com/news/3268635-rsp-permian-to-launch-15m-share-secondary-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3268635-rsp-permian-to-launch-15m-share-secondary-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268629\" data-ts=\"1495138576\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPS\" target=\"_blank\">GPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268629-gap-beats-0_07-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gap beats by $0.07, beats on revenue</a></h4><ul><li>Gap (NYSE:<a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a>): Q1 EPS of $0.36 <font color='green'>beats by $0.07</font>.</li><li>Revenue of $3.44B (flat Y/Y) <font color='green'>beats by $50M</font>.</li><li>Shares <font color='green'>+6%</font>.</li><li><a href='https://seekingalpha.com/pr/16838224-gap-inc-reports-first-quarter-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3268629\" data-linked=\"Gap beats by $0.07, beats on revenue\" data-tweet=\"$GPS - Gap beats by $0.07, beats on revenue https://seekingalpha.com/news/3268629-gap-beats-0_07-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3268629-gap-beats-0_07-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268625\" data-ts=\"1495138571\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADSK\" target=\"_blank\">ADSK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268625-autodeskplus-5_9-on-q1-beat-solid-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Autodesk +5.9% on Q1 beat, solid guidance</a></h4><ul>   <li>Autodesk (NASDAQ:<a href='https://seekingalpha.com/symbol/ADSK' title='Autodesk, Inc.'>ADSK</a>) is <font color='green'>up 5.9%</font> after hours following a <a href=\"https://seekingalpha.com/news/3268602-autodesk-beats-0_08-beats-revenue\" target=\"_blank\">Q1 earnings</a> beat on top and bottom lines and solid current-quarter guidance.</li>    <li>Revenue fell 5%, but amid a transition in the company's business model with more revenue recognized ratably rather than up front. Deferred revenue rose 18%, to $1.8B.</li>    <li>Subscription plan (new model) subs rose 233,000 from Q4, to 1.32M. Total subs rose 186,000 to 3.29M.</li>    <li>Total annualized recurring revenue came to $1.74B (up 18% Y/Y); subscription plan ARR was $692M, up 103% Y/Y.</li>    <li>Revenue breakout: Maintenance, $263.6M (down 7.3%); Subscription, $173.4M (up 103%); License and other, $48.7M (down 65.7%).</li>    <li>For Q2 2018, the company's guiding to revenue of $488M-$500M (vs. consensus for $488M) and non-GAAP EPS of -$0.18 to -$0.14 (vs. expectations for -$0.15). For the full year, it's forecasting revenue of $2B-$2.05B (vs. consensus for $2.02B) and EPS of -$0.73 to -$0.56 (vs. expected -$0.60).</li>    <li><a href=\"http://www.autodesk.com/investor\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16838162-autodesk-reports-strong-first-quarter-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3268625\" data-linked=\"Autodesk +5.9% on Q1 beat, solid guidance\" data-tweet=\"$ADSK - Autodesk +5.9% on Q1 beat, solid guidance https://seekingalpha.com/news/3268625-autodeskplus-5_9-on-q1-beat-solid-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3268625-autodeskplus-5_9-on-q1-beat-solid-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268617\" data-ts=\"1495138400\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSBD\" target=\"_blank\">GSBD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268617-goldman-sachs-bdc-raising-capital-shares-down-1_9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman Sachs BDC raising capital; shares down 1.9%</a></h4><ul><li>The company<a href=\"https://seekingalpha.com/pr/16838211-goldman-sachs-bdc-inc-announces-offering-shares-common-stock\" target=\"_blank\"> is selling 3.25M shares</a>, with underwriter greenshoe of 487.5K shares.</li><li>Last reported NAV per share (March 31) was $18.26, so the offering comes at well above book (today's close was $23.08).</li><li><a href='https://seekingalpha.com/symbol/GSBD' title='Goldman Sachs BDC'>GSBD</a><font color='red'> -1.9%</font>&nbsp;after hours to $22.65.</li></ul><div class=\"tiny-share-widget\" data-id=\"3268617\" data-linked=\"Goldman Sachs BDC raising capital; shares down 1.9%\" data-tweet=\"$GSBD - Goldman Sachs BDC raising capital; shares down 1.9% https://seekingalpha.com/news/3268617-goldman-sachs-bdc-raising-capital-shares-down-1_9?source=tweet\" data-url=\"https://seekingalpha.com/news/3268617-goldman-sachs-bdc-raising-capital-shares-down-1_9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268615\" data-ts=\"1495138313\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCK\" target=\"_blank\">MCK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268615-mckesson-beats-0_42-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">McKesson beats by $0.42, misses on revenue</a></h4><ul><li>McKesson (NYSE:<a href='https://seekingalpha.com/symbol/MCK' title='McKesson Corporation'>MCK</a>): Q4 EPS of $3.42 <font color='green'>beats by $0.42</font>.</li><li>Revenue of $48.7B (+4.3% Y/Y) <font color='red'>misses by $780M</font>.</li><li>Shares <font color='green'>+4.8%</font>.</li><li><a href='https://seekingalpha.com/pr/16838217-mckesson-reports-fiscal-2017-fourth-quarter-full-year-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3268615\" data-linked=\"McKesson beats by $0.42, misses on revenue\" data-tweet=\"$MCK - McKesson beats by $0.42, misses on revenue https://seekingalpha.com/news/3268615-mckesson-beats-0_42-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3268615-mckesson-beats-0_42-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268613\" data-ts=\"1495138252\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRM\" target=\"_blank\">CRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268613-salesforce-com-beats-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Salesforce.com beats by $0.02, beats on revenue</a></h4><ul><li>Salesforce.com (NYSE:<a href='https://seekingalpha.com/symbol/CRM' title='Salesforce.com, Inc.'>CRM</a>): Q1 EPS of $0.28 <font color='green'>beats by $0.02</font>.</li><li>Revenue of $2.39B (+24.5% Y/Y) <font color='green'>beats by $40M</font>.</li><li>Shares <font color='green'>+1.42%</font>.</li><li><a href='https://seekingalpha.com/pr/16838197-salesforce-announces-fiscal-2018-first-quarter-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3268613\" data-linked=\"Salesforce.com beats by $0.02, beats on revenue\" data-tweet=\"$CRM - Salesforce.com beats by $0.02, beats on revenue https://seekingalpha.com/news/3268613-salesforce-com-beats-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3268613-salesforce-com-beats-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268597\" data-ts=\"1495137489\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBI\" target=\"_blank\">CBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268597-cb-and-i-hits-52-week-low-analyst-says-time-to-buy-on-weakness\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CB&amp;I hits 52-week low, but analyst says time to buy on weakness</a></h4><ul>     <li>Chicago Bridge &amp;&nbsp;Iron (<a href='https://seekingalpha.com/symbol/CBI' title='Chicago Bridge & Iron Company'>CBI</a> <font color='red'>-4.3%</font>) sinks to a near seven-year low and has now plunged by more than a third in the wake of its <a href=\"https://seekingalpha.com/news/3265269-cb-minus-7-percent-big-q1-miss-guides-full-year-earnings-consensus\" target=\"_blank\">wide Q1 earnings miss</a> and weaker than expected FY 2017 earnings guidance.</li><li>MKM analyst Daniel Scott blames the decline on several factors, including amendments to its senior facilities, the possibility that it will violate covenants within the next few quarters, and charges on three projects.</li><li>But the analyst says CBI's stock valuation is too compelling to ignore, and he says the company has obtained many new deals that set the stage for  \"stable earnings\" going forward; he trims his stock price target to $34 from $41 but keeps a Buy rating and recommends <a href=\"https://thefly.com/landingPageNews.php?id=2554569&amp;headline=CBI-CBampI-should-be-bought-on-weakness--says--MKM-Partners\" target=\"_blank\">buying the shares on weakness</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3268597\" data-linked=\"CB&amp;I hits 52-week low, but analyst says time to buy on weakness\" data-tweet=\"$CBI - CB&amp;I hits 52-week low, but analyst says time to buy on weakness https://seekingalpha.com/news/3268597-cb-and-i-hits-52-week-low-analyst-says-time-to-buy-on-weakness?source=tweet\" data-url=\"https://seekingalpha.com/news/3268597-cb-and-i-hits-52-week-low-analyst-says-time-to-buy-on-weakness\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268590\" data-ts=\"1495136378\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STRP\" target=\"_blank\">STRP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268590-solus-ceo-globalstar-undervalued-on-spectrum-interest\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Solus CEO: Globalstar undervalued on spectrum interest</a></h4><ul>   <li>Globalstar (<a href=\"http://seekingalpha.com/symbol/GSAT\" target=\"_blank\">GSAT</a> <font color='green'>+2.8%</font>) is getting good vibes from Solus CEO Chris Pucillo, who says the stock should be worth \"quite a bit more.\"</li>    <li>Speaking to Bloomberg TV at the SALT conference, Pucillo acknowledges that realizing that value is \"a timing issue\" and might take a while.</li>    <li>But in the wake of Verizon's last-minute <a href=\"https://seekingalpha.com/news/3266247-wsj-verizon-wins-straight-path-sweepstakes-3_1b-buyout-deal\" target=\"_blank\">topping bid for Straight Path</a> (NYSEMKT:<a href='https://seekingalpha.com/symbol/STRP' title='Straight Path Communications Inc.'>STRP</a>) and its millimeter wave spectrum, Globalstar's spectrum could be \"very interesting\" to Google, Facebook and even Amazon.com, he says. And Verizon is still playing catch-up in the area.</li>    <li>Weighing in on an at-risk SoftBank (<a href=\"http://seekingalpha.com/symbol/SFTBY\" target=\"_blank\">SFTBY</a> <font color='red'>-0.4%</font>) deal to <a href=\"https://seekingalpha.com/news/3268307-intelsat-sweetens-exchange-offers-bondholder-dispute-updated\" target=\"_blank\">merge its OneWeb with Intelsat</a> (<a href=\"http://seekingalpha.com/symbol/I\" target=\"_blank\">I</a> <font color='green'>+6.6%</font>): There's a big deal risk, but if SoftBank will pay a bit more, \"they'll get it.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3268590\" data-linked=\"Solus CEO: Globalstar undervalued on spectrum interest\" data-tweet=\"$STRP $STRP $GSAT - Solus CEO: Globalstar undervalued on spectrum interest https://seekingalpha.com/news/3268590-solus-ceo-globalstar-undervalued-on-spectrum-interest?source=tweet\" data-url=\"https://seekingalpha.com/news/3268590-solus-ceo-globalstar-undervalued-on-spectrum-interest\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268587\" data-ts=\"1495135628\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MWA\" target=\"_blank\">MWA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268587-mueller-waterplus-1_5-on-gabelli-recommendation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mueller Water +1.5% on Gabelli recommendation</a></h4><ul><li>Mario Gabelli tells CNBC that he is <a href=\"http://www.cnbc.com/2017/05/18/mario-gabelli-these-trump-stocks-will-be-fine-even-without-trump.html\" target=\"_blank\">betting on infrastructure</a> even if the Trump administration fails to deliver on  its $1T plan to improve roads, tunnels and bridges.</li><li>The Gameco founder and chairman says he especially like Mueller Water Products (<a href='https://seekingalpha.com/symbol/MWA' title='Mueller Water Products, Inc.'>MWA</a> <font color='green'>+1.5%</font>), which he says has recently come under new leadership and is responsible for  providing at least half the fire hydrants in the U.S.</li><li>Gabells has previously spoken favorably of infrastructure, saying,  \"Infrastructure is important because it helps fiscal stimulation, it  offsets monetary policy, it helps the jobs in the middle of the country,  it helps everyone.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3268587\" data-linked=\"Mueller Water +1.5% on Gabelli recommendation\" data-tweet=\"$MWA - Mueller Water +1.5% on Gabelli recommendation https://seekingalpha.com/news/3268587-mueller-waterplus-1_5-on-gabelli-recommendation?source=tweet\" data-url=\"https://seekingalpha.com/news/3268587-mueller-waterplus-1_5-on-gabelli-recommendation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268584\" data-ts=\"1495134842\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNK\" target=\"_blank\">MNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268584-chanos-pitches-shorts-of-mallinckrodt-and-express-scripts-salt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chanos pitches shorts of Mallinckrodt and Express Scripts at SALT</a></h4><ul><li>Mallinckrodt (NYSE:<a href='https://seekingalpha.com/symbol/MNK' title='Mallinckrodt PLC'>MNK</a>) is a highly levered, one drug company, says Jim Chanos, presenting at the SALT conference. And that one drug - Acthar Gel - is \"egregiously overpriced.\" Look for a congressional review.</li><li>He next goes on to the \"murky alliance\" between MNK and Express Scripts (NASDAQ:<a href='https://seekingalpha.com/symbol/ESRX' title='Express Scripts, Inc.'>ESRX</a>).</li><li>MNK remains<font color='red'> lower by 4%</font>, and ESRX has given up early gains, now flat on the session.</li></ul><div class=\"tiny-share-widget\" data-id=\"3268584\" data-linked=\"Chanos pitches shorts of Mallinckrodt and Express Scripts at SALT\" data-tweet=\"$MNK $MNK $ESRX - Chanos pitches shorts of Mallinckrodt and Express Scripts at SALT https://seekingalpha.com/news/3268584-chanos-pitches-shorts-of-mallinckrodt-and-express-scripts-salt?source=tweet\" data-url=\"https://seekingalpha.com/news/3268584-chanos-pitches-shorts-of-mallinckrodt-and-express-scripts-salt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268582\" data-ts=\"1495134426\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DISH\" target=\"_blank\">DISH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268582-t-mobile-cfo-sprints-logical-partner\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">T-Mobile CFO: Sprint&#39;s our most logical partner</a></h4><ul>   <li>Speaking at a conference, T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color='green'>+3.3%</font>) CFO Braxton Carter acknowledges that Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color='green'>+7.7%</font>) is the <a href=\"https://www.bloomberg.com/news/articles/2017-05-18/t-mobile-calls-sprint-most-logical-partner-as-deal-talk-heats-up\" target=\"_blank\">most logical partner for the company</a> in upcoming industry consolidation.</li>    <li>The Obama administration preferred a four-player U.S. wireless market, but the Trump administration could think differently -- and the case for a stronger competitor to AT&amp;T (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color='green'>+1.7%</font>) and Verizon (<a href=\"http://seekingalpha.com/symbol/VZ\" target=\"_blank\">VZ</a> <font color='green'>+1.6%</font>) is &ldquo;even more true today because of Sprint&rsquo;s precarious financial position ... The combined company would have the ability and the resources to really put all of that spectrum to work for the benefits of consumers and businesses everywhere.&rdquo;</li>    <li>If not with each other, then Sprint and T-Mobile figure to be heavily at play in talk of combinations that could include cablecos like Comcast (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color='green'>+1.9%</font>) or Charter (<a href=\"http://seekingalpha.com/symbol/CHTR\" target=\"_blank\">CHTR</a> <font color='green'>+1.2%</font>), or a spectrum-heavy tie-up with Dish Network (NASDAQ:<a href='https://seekingalpha.com/symbol/DISH' title='DISH Network Corporation'>DISH</a>).</li>    <li>While Carter speaks in New York, Sprint chief Marcelo Claure is in Washington, D.C., for meetings with officials including regulators.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3268582\" data-linked=\"T-Mobile CFO: Sprint&#39;s our most logical partner\" data-tweet=\"$DISH $DISH $TMUS - T-Mobile CFO: Sprint&#39;s our most logical partner https://seekingalpha.com/news/3268582-t-mobile-cfo-sprints-logical-partner?source=tweet\" data-url=\"https://seekingalpha.com/news/3268582-t-mobile-cfo-sprints-logical-partner\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>70&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268579\" data-ts=\"1495134238\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268579-sarepta-hired-former-fda-lawyer-to-help-guide-parents-testimony-during-eteplirsen-ad-comm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sarepta hired former FDA lawyer to help guide parents&#39; testimony during eteplirsen Ad Comm review</a></h4><ul><li>Sarepta Therapeutics (<a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a> <font color='green'>+3%</font>) <a href=\"https://thefly.com/landingPageNews.php?id=2554758&amp;headline=SRPT-Sarepta-worked-with-consultant-to-guide-parents-FDA-testimony-WSJ-reports\" target=\"_blank\">allegedly engaged</a> former FDA lawyer Frank Sasinowski to coach the parents on how to testify during the FDA's advisory committee meeting for DMD med eteplirsen with the aim of convincing them to vote for the drug. According to two reporters from the Wall Street Journal, the majority of the panel were unaware of Sasinowski's role. Committee member Dr. Bruce Ovbiagele said more of his peers \"might have voted no if they were aware\" of his involvement.</li><li>The FDA approved the drug to treat DMD on September 19, 2016 despite a 7-6 committee vote against accelerated approval.</li><li>Source: The Fly</li></ul><div class=\"tiny-share-widget\" data-id=\"3268579\" data-linked=\"Sarepta hired former FDA lawyer to help guide parents&#39; testimony during eteplirsen Ad Comm review\" data-tweet=\"$SRPT - Sarepta hired former FDA lawyer to help guide parents&#39; testimony during eteplirsen Ad Comm review https://seekingalpha.com/news/3268579-sarepta-hired-former-fda-lawyer-to-help-guide-parents-testimony-during-eteplirsen-ad-comm?source=tweet\" data-url=\"https://seekingalpha.com/news/3268579-sarepta-hired-former-fda-lawyer-to-help-guide-parents-testimony-during-eteplirsen-ad-comm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268581\" data-ts=\"1495134229\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IRM\" target=\"_blank\">IRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268581-iron-mountain-short-pitched-salt-conference\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Iron Mountain short pitched at SALT conference</a></h4><ul><li>Iron Mountain (NYSE:<a href='https://seekingalpha.com/symbol/IRM' title='Iron Mountain Inc.'>IRM</a>) has a significant cost problem relative to peers, says Eminence Capital's Ricky Sandler. High leverage, secular headwinds, and dividend coverage issues suggest&nbsp;<font color='red'>50% downside</font>.</li><li>Shares have given up about half of their gain on the session, currently&nbsp;<font color='green'>higher by 0.6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3268581\" data-linked=\"Iron Mountain short pitched at SALT conference\" data-tweet=\"$IRM - Iron Mountain short pitched at SALT conference https://seekingalpha.com/news/3268581-iron-mountain-short-pitched-salt-conference?source=tweet\" data-url=\"https://seekingalpha.com/news/3268581-iron-mountain-short-pitched-salt-conference\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268578\" data-ts=\"1495134028\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268578-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ATHN' title='athenahealth, Inc.'>ATHN</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/PTI' title='Proteostasis Therapeutics'>PTI</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/IPDN' title='Professional Diversity Network'>IPDN</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/PNTR' title='Pointer Telocation Ltd.'>PNTR</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/I' title='Intelsat SA'>I</a> <font color='green'>+9%</font>.</li><li><b>Losers:&nbsp;</b><a href='https://seekingalpha.com/symbol/TSU' title='TIM Participaes S.A.'>TSU</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/PSTG' title='Pure Storage'>PSTG</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/RUBI' title='The Rubicon Project, Inc.'>RUBI</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/VIV' title='Telefonica Brasil, S.A'>VIV</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/CSCO' title='Cisco Systems, Inc.'>CSCO</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3268578\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$ATHN $PTI $IPDN - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3268578-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3268578-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268576\" data-ts=\"1495133295\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268576-facebook-to-broadcast-weekly-mlb-games-esl-matches\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook to broadcast weekly MLB games, ESL matches</a></h4><ul>   <li>Another notch in Facebook's (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color='green'>+2.1%</font>) video belt comes as the company has a deal to broadast a <a href=\"http://abcnews.go.com/Entertainment/wireStory/facebook-stream-mlb-game-friday-starting-week-47492855\" target=\"_blank\">live Major League Baseball game</a> each Friday.</li>    <li>That's a 20-game package; the deal starts this week, with Colorado at Cincinnati.</li>    <li>Twitter's (<a href=\"http://seekingalpha.com/symbol/TWTR\" target=\"_blank\">TWTR</a> <font color='green'>+1.3%</font>) feed, which was of an MLB game each Friday, will be bumped to Tuesdays.</li>    <li>Meanwhile, Facebook will partner with <a href=\"https://www.cnet.com/news/facebook-is-going-to-start-streaming-esports/\" target=\"_blank\">e-Sports league ESL</a> to broadcast content: more than 5,500 hours of live-streaming content, some 1,500 hours of which will be exclusive to Facebook.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3268576\" data-linked=\"Facebook to broadcast weekly MLB games, ESL matches\" data-tweet=\"$FB $FB $TWTR - Facebook to broadcast weekly MLB games, ESL matches https://seekingalpha.com/news/3268576-facebook-to-broadcast-weekly-mlb-games-esl-matches?source=tweet\" data-url=\"https://seekingalpha.com/news/3268576-facebook-to-broadcast-weekly-mlb-games-esl-matches\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268575\" data-ts=\"1495133182\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268575-sarepta-perks-up-3-after-tourbillons-karp-says-long-stock\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sarepta perks up 3% after Tourbillon&#39;s Karp says he&#39;s long the stock</a></h4><ul><li>Sarepta Therapeutics (<a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a> <font color='green'>+3.4%</font>) jumps on average volume after Tourbillion investment chief Jason Karp said he has a long position. During the SALT investment conference, he commented that he sees as much as a 200% upside in the stock over the next two years.</li><li>Source: The Fly</li></ul><div class=\"tiny-share-widget\" data-id=\"3268575\" data-linked=\"Sarepta perks up 3% after Tourbillon&#39;s Karp says he&#39;s long the stock\" data-tweet=\"$SRPT - Sarepta perks up 3% after Tourbillon&#39;s Karp says he&#39;s long the stock https://seekingalpha.com/news/3268575-sarepta-perks-up-3-after-tourbillons-karp-says-long-stock?source=tweet\" data-url=\"https://seekingalpha.com/news/3268575-sarepta-perks-up-3-after-tourbillons-karp-says-long-stock\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268593\" data-ts=\"1495132794\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOV\" target=\"_blank\">NOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268593-national-oilwell-varco-to-expand-tubular-technologies-in-saudi-arabia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">National Oilwell Varco to expand tubular technologies in Saudi Arabia</a></h4><ul>     <li>National Oilwell Varco (<a href='https://seekingalpha.com/symbol/NOV' title='National Oilwell Varco, Inc.'>NOV</a> <font color='green'>+2.1%</font>) is up after announcing <a href=\"https://seekingalpha.com/pr/16836853-nov-expands-ability-deliver-market-leading-tubular-technologies-saudi-arabia\" target=\"_blank\">groundbreaking</a> on two new, composite-pipe manufacturing facilities plants at its MODON 3 complex in Saudi Arabia.</li>     <li>NOV says the plants will significantly strengthen its market leading positions in providing composite pipe technologies and tubular coatings within Saudi Arabia.</li>     <li>NOV expects both facilities to be operational in Q1 2018.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3268593\" data-linked=\"National Oilwell Varco to expand tubular technologies in Saudi Arabia\" data-tweet=\"$NOV - National Oilwell Varco to expand tubular technologies in Saudi Arabia https://seekingalpha.com/news/3268593-national-oilwell-varco-to-expand-tubular-technologies-in-saudi-arabia?source=tweet\" data-url=\"https://seekingalpha.com/news/3268593-national-oilwell-varco-to-expand-tubular-technologies-in-saudi-arabia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268567\" data-ts=\"1495130432\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268567-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GST' title='Gastar Exploration Inc.'>GST</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/PACD' title='Pacific Drilling SA'>PACD</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/HGT-OLD' title='Hugoton Royalty Trust'>HGT-OLD</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> PBR-A <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/SID' title='Companhia Siderurgica Nacional'>SID</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/PBR' title='Petrobras - Petroleo Brasileiro S.A.'>PBR</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/GGB' title='Gerdau S.A.'>GGB</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/UGP' title='Ultrapar Participacoes S.A.'>UGP</a> <font color='red'>-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3268567\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$GST $PACD $HGT-OLD - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3268567-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3268567-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268565\" data-ts=\"1495129674\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KMX\" target=\"_blank\">KMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268565-carmax-rallies-after-wedbush-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CarMax rallies after Wedbush upgrade</a></h4><ul>     <li>Wedbush Securities <a href=\"https://www.streetinsider.com/Analyst+Comments/Wedbush+Upgrades+CarMax+%28KMX%29+to+Outperform%3B+Give+Credit+for+Pulling+Ahead+of+the+Pack/12920437.html\" target=\"_blank\">upgrades</a> CarMax (NYSE:<a href='https://seekingalpha.com/symbol/KMX' title='CarMax Group'>KMX</a>) to Outperform from Neutral.</li>     <li>\"With credit concerns restrained, continued strength in KMX&rsquo;s core business leads us to boost our earnings estimates above consensus,\" writes analyst Sthe Basham.</li><li>Shares of CarMax are&nbsp;<font color='green'>up 7%</font>&nbsp;to jump back to their highest level since mid-March.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3268565\" data-linked=\"CarMax rallies after Wedbush upgrade\" data-tweet=\"$KMX - CarMax rallies after Wedbush upgrade https://seekingalpha.com/news/3268565-carmax-rallies-after-wedbush-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3268565-carmax-rallies-after-wedbush-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268563\" data-ts=\"1495128984\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268563-financials-top-gainers-losers-of-1-30-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top Gainers / Losers as of 1:30 PM</a></h4><ul>     <li><b>Gainers:</b> WAC <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/CPSS' title='Consumer Portfolio Services, Inc.'>CPSS</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/BSBR' title='Banco Santander &#40;Brasil&#41; S.A.'>BSBR</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/BBD' title='Banco Bradesco, S.A.'>BBD</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/ITUB' title='Itau Unibanco Holding S.A.'>ITUB</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/BBDO' title='Banco Bradesco S.A.'>BBDO</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/LND' title='BrasilAgro - Brazilian Agricultural Real Estate Co ADR'>LND</a> <font color='red'>-14%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3268563\" data-linked=\"Financials - Top Gainers / Losers as of 1:30 PM\" data-tweet=\"$DHCP $CCCR-OLD $CPSS - Financials - Top Gainers / Losers as of 1:30 PM https://seekingalpha.com/news/3268563-financials-top-gainers-losers-of-1-30-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3268563-financials-top-gainers-losers-of-1-30-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268560\" data-ts=\"1495128735\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VCYT\" target=\"_blank\">VCYT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268560-anthem-to-cover-veracytes-thyroid-cancer-test-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anthem to cover Veracyte&#39;s thyroid cancer test; shares up 2%</a></h4><ul><li>Anthem has <a href=\"https://seekingalpha.com/pr/16837902-veracyte-announces-anthem-coverage-afirma-gene-expression-classifier-use-thyroid-cancer\" target=\"_blank\">decided to cover</a> Veracyte's (<a href='https://seekingalpha.com/symbol/VCYT' title='Veracyte, Inc.'>VCYT</a> <font color='green'>+2%</font>) Afirma Gene Expression Classifier for use in the diagnosis of thyroid cancer for its 40M members. The test identifies patients with benign thyroid nodules whose biopsy results are indeterminate, thereby enabling them to avoid diagnostic surgery.</li></ul><div class=\"tiny-share-widget\" data-id=\"3268560\" data-linked=\"Anthem to cover Veracyte&#39;s thyroid cancer test; shares up 2%\" data-tweet=\"$VCYT - Anthem to cover Veracyte&#39;s thyroid cancer test; shares up 2% https://seekingalpha.com/news/3268560-anthem-to-cover-veracytes-thyroid-cancer-test-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3268560-anthem-to-cover-veracytes-thyroid-cancer-test-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268556\" data-ts=\"1495127893\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LJPC\" target=\"_blank\">LJPC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268556-results-from-la-jolla-pharmas-late-stage-study-of-ljpcminus-501-to-be-published-in-nejm-may\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Results from La Jolla Pharma&#39;s late-stage study of LJPC-501 to be published in the NEJM May 21; shares up 16%</a></h4><ul><li>Investors appear bullish ahead of the <a href=\"https://seekingalpha.com/filing/3557438\" target=\"_blank\">publication </a>of Phase 3 data on La Jolla Pharmaceutical's (<a href='https://seekingalpha.com/symbol/LJPC' title='La Jolla Pharmaceutical Co.'>LJPC</a> <font color='green'>+16.3%</font>) LJPC-501. Results from the <a href=\"https://clinicaltrials.gov/ct2/show/NCT02338843?term=athos-3&amp;rank=1\" target=\"_blank\">ATHOS-3</a> trial will be published this Sunday, May 21, in the <em>New England Journal of Medicine</em>.</li><li>In March, the company announced that the study, in patients with a life-threatening drop in blood pressure, was successful although there were questions about the drug's effect on mortality.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3250724-lajolla-pharma-pressure-questions-ljpcminus-501s-mortality-benefit-shares-slip-2-percent\" target=\"_blank\">LaJolla Pharma under pressure on questions about LJPC-501's mortality benefit; shares slip 2%</a> (March 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3268556\" data-linked=\"Results from La Jolla Pharma&#39;s late-stage study of LJPC-501 to be published in the NEJM May 21; shares up 16%\" data-tweet=\"$LJPC - Results from La Jolla Pharma&#39;s late-stage study of LJPC-501 to be published in the NEJM May 21; shares up 16% https://seekingalpha.com/news/3268556-results-from-la-jolla-pharmas-late-stage-study-of-ljpcminus-501-to-be-published-in-nejm-may?source=tweet\" data-url=\"https://seekingalpha.com/news/3268556-results-from-la-jolla-pharmas-late-stage-study-of-ljpcminus-501-to-be-published-in-nejm-may\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268549\" data-ts=\"1495127084\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NSTG\" target=\"_blank\">NSTG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268549-nanostring-revises-guidance-after-astellas-and-pfizer-ax-late-stage-study-of-enzalutamide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NanoString revises guidance after Astellas and Pfizer ax late-stage study of enzalutamide + chemo in TNBC, $10.6M in deferred revs no longer; shares off 2%</a></h4><ul><li>NanoString Technologies (<a href='https://seekingalpha.com/symbol/NSTG' title='NanoString Technologies'>NSTG</a> <font color='red'>-1.6%</font>) will <a href=\"https://www.sec.gov/Archives/edgar/data/1401708/000140170817000032/nstg-051817x8k.htm\" target=\"_blank\">record</a> $10.6M in deferred revenue as collaboration revenue this year after Astellas Pharma (<a href='https://seekingalpha.com/symbol/ALPMF' title='Astellas Pharma, Inc.'>OTCPK:ALPMF</a>)(<a href='https://seekingalpha.com/symbol/ALPMY' title='Astellas Pharma, Inc. ADR'>OTCPK:ALPMY</a>) and Pfizer's (<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color='green'>+0.1%</font>) decision to terminate their planned Phase 3 clinical trial, ENDEAR, evaluating enzalutamide and paclitaxel in patients with advanced triple-negative breast cancer &#40;TNBC&#41;.</li><li>The company had received $12.0M in total payments related to its role in the collaboration.</li><li>Management has revised its 2017 guidance as follows: Collaboration revenue: $25.0M - 26.0M from $19.0M - 20M; total revenue: $106.0M - 111.0M from $100M - 105M.</li><li>Q2 guidance: Collaboration revenue: $14.0M; total revenue: $33.5M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3268549\" data-linked=\"NanoString revises guidance after Astellas and Pfizer ax late-stage study of enzalutamide + chemo in TNBC, $10.6M in deferred revs no longer; shares off 2%\" data-tweet=\"$NSTG $NSTG $ALPMF - NanoString revises guidance after Astellas and Pfizer ax late-stage study of enzalutamide + chemo in TNBC, $10.6M in deferred revs no longer; shares off 2% https://seekingalpha.com/news/3268549-nanostring-revises-guidance-after-astellas-and-pfizer-ax-late-stage-study-of-enzalutamide?source=tweet\" data-url=\"https://seekingalpha.com/news/3268549-nanostring-revises-guidance-after-astellas-and-pfizer-ax-late-stage-study-of-enzalutamide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268547\" data-ts=\"1495126214\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268547-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GLYC' title='GlycoMimetics'>GLYC</a> <font color='green'>+101%</font>. WAC <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/ATHN' title='athenahealth, Inc.'>ATHN</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/CUR' title='Neuralstem, Inc.'>CUR</a> <font color='green'>+18%</font>. ETRM <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/ACHN' title='Achillion Pharmaceuticals, Inc.'>ACHN</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/CNET' title='ChinaNet Online Holdings, Inc.'>CNET</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/SORL' title='SORL Auto Parts, Inc.'>SORL</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/BDSI' title='BioDelivery Sciences International, Inc.'>BDSI</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SMRT' title='Stein Mart, Inc.'>SMRT</a> <font color='red'>-38%</font>. <a href='https://seekingalpha.com/symbol/ELGX' title='Endologix Inc'>ELGX</a> <font color='red'>-35%</font>. <a href='https://seekingalpha.com/symbol/ASNA' title='Ascena Retail Group Inc'>ASNA</a> <font color='red'>-29%</font>. <a href='https://seekingalpha.com/symbol/GOL' title='GOL Linhas Areas Inteligentes S.A.'>GOL</a> <font color='red'>-27%</font>. <a href='https://seekingalpha.com/symbol/EBR' title='Centrais Eletricas Brasileiras S.A. - Eletrobras'>EBR</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/CIG' title='Companhia Energtica de Minas Gerais - CEMIG'>CIG</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/BSBR' title='Banco Santander &#40;Brasil&#41; S.A.'>BSBR</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/PBR.A' title='Petrobras - Petrleo Brasileiro S.A.'>PBR.A</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/BBD' title='Banco Bradesco, S.A.'>BBD</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/ITUB' title='Itau Unibanco Holding S.A.'>ITUB</a>&nbsp;<font color='red'>-19%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3268547\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$GLYC $DHCP $ATHN - Midday Gainers / Losers https://seekingalpha.com/news/3268547-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3268547-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268542\" data-ts=\"1495124968\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBR\" target=\"_blank\">PBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268542-petrobras-turnaround-yield-first-dividend-in-years-in-2017-ceo-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Petrobras turnaround could yield first dividend in years in 2017, CEO says</a></h4><ul>     <li>Petrobras (<a href='https://seekingalpha.com/symbol/PBR' title='Petrobras - Petroleo Brasileiro S.A.'>PBR</a> <font color='red'>-17.1%</font>) will pay its <a href=\"http://www.reuters.com/article/us-brazil-petrobras-idUSKCN18D2Y6\" target=\"_blank\">first shareholder dividend in three years</a> if the company turns a profit in 2017, CEO Pedro Parente says.</li>     <li>Rising production from Brazil's offshore fields is helping Parente turn PBR around from its low point in 2014, when the company last paid dividends; <a href=\"https://finance.yahoo.com/news/brazils-petrobras-says-april-output-234745630.html\" target=\"_blank\">April output held steady</a> at 2.72M boe/day, including pre-salt production of 1.5M boe/day, stable from March but 50% higher than in the same month a year earlier.</li>     <li>Parente's optimistic view is drowned out today by <a href=\"https://seekingalpha.com/news/3268316-petrobras-vale-plunge-brazil-president-reportedly-discussed-hush-money\" target=\"_blank\">Brazil's latest political scandal</a>, sending Brazilian stocks <a href=\"https://seekingalpha.com/news/3268439-brazil-crashes-new-political-scandal-bovespa-10-percent\" target=\"_blank\">broadly and sharply lower</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3268542\" data-linked=\"Petrobras turnaround could yield first dividend in years in 2017, CEO says\" data-tweet=\"$PBR - Petrobras turnaround could yield first dividend in years in 2017, CEO says https://seekingalpha.com/news/3268542-petrobras-turnaround-yield-first-dividend-in-years-in-2017-ceo-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3268542-petrobras-turnaround-yield-first-dividend-in-years-in-2017-ceo-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268540\" data-ts=\"1495124171\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABEV\" target=\"_blank\">ABEV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268540-deutsche-bank-recommends-buying-ambev-weakness\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank recommends buying into Ambev weakness</a></h4><ul>     <li>Deutsche Bank thinks the decline in Ambev (<a href='https://seekingalpha.com/symbol/ABEV' title='Ambev - Companhia de Bebidas das Americas'>ABEV</a> <font color='red'>-10.9%</font>) is a buying opportunity for investors.</li>     <li>\"As a market bellwether and liquid stock, ABEV is down significantly on the back of political turmoil in Brazil and associated BRL weakness,\" reads the DB note.</li><li>Ambev is added to the short-term buy list at the bank.</li><li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3268516-brazil-turmoil-hits-consumer-products-sellers\" target=\"_blank\">Brazil turmoil hits consumer products sellers</a> (May 18)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3268540\" data-linked=\"Deutsche Bank recommends buying into Ambev weakness\" data-tweet=\"$ABEV - Deutsche Bank recommends buying into Ambev weakness https://seekingalpha.com/news/3268540-deutsche-bank-recommends-buying-ambev-weakness?source=tweet\" data-url=\"https://seekingalpha.com/news/3268540-deutsche-bank-recommends-buying-ambev-weakness\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268537\" data-ts=\"1495123292\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268537-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SORL' title='SORL Auto Parts, Inc.'>SORL</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/VRTV' title='Veritiv'>VRTV</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/PERY' title='Perry Ellis International Inc.'>PERY</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/SYPR' title='Sypris Solutions, Inc.'>SYPR</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ABEV' title='Ambev - Companhia de Bebidas das Americas'>ABEV</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/BRFS' title='BRF-Brasil Foods S.A.'>BRFS</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/AVP' title='Avon Products, Inc.'>AVP</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/VRS' title='Verso Corporation'>VRS</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/KOSS' title='Koss Corporation'>KOSS</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3268537\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$SORL $VRTV $PERY - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3268537-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3268537-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268534\" data-ts=\"1495122733\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPB\" target=\"_blank\">SPB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268534-spectrum-brands-hrg-group-merger-suggestion-in-air\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spectrum Brands-HRG Group merger suggestion in the air</a></h4><ul> <li>Stakeholder Tourbillon Capital Partners sends a letter to the board at Spectrum Brands (<a href='https://seekingalpha.com/symbol/SPB' title='Spectrum Brands, Inc.'>SPB</a> <font color='green'>+0.6%</font>) asking it to consider a potential downstream merger with majority shareholder HRG Group (<a href='https://seekingalpha.com/symbol/HRG' title='HRG Group, Inc.'>HRG</a> <font color='green'>+0.5%</font>).</li>     <li>&ldquo;As a       long-time shareholder of Spectrum Brands, we support the Company&rsquo;s       standalone business strategy, but also believe the right transaction       with HRG could yield 70-90% upside to SPB shares,\" writes Tourbillon CEO Jason Karp.</li><li>&ldquo;To protect the interests of SPB shareholders and maximize shareholder       value, we expect Spectrum&rsquo;s Board to form a special committee, retain       independent advisors, and seek approval by a majority of Spectrum&rsquo;s       minority shareholders.\"</li><li>The call to action arrives with shares of Spectrum Brands up 11% over the last 52 weeks.</li><li>Source: <a href=\"https://seekingalpha.com/pr/16837444-tourbillon-sends-letter-spectrum-brands-board-directors\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3268534\" data-linked=\"Spectrum Brands-HRG Group merger suggestion in the air\" data-tweet=\"$SPB $SPB $HRG - Spectrum Brands-HRG Group merger suggestion in the air https://seekingalpha.com/news/3268534-spectrum-brands-hrg-group-merger-suggestion-in-air?source=tweet\" data-url=\"https://seekingalpha.com/news/3268534-spectrum-brands-hrg-group-merger-suggestion-in-air\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268531\" data-ts=\"1495122022\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHP\" target=\"_blank\">BHP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268531-elliott-calls-barcelona-meeting-bhp-constructive\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Elliott calls Barcelona meeting with BHP &quot;constructive&quot;</a></h4><ul>     <li>Elliott Management says yesterday's meeting with BHP (<a href='https://seekingalpha.com/symbol/BHP' title='BHP Billiton Limited'>BHP</a> <font color='green'>+1.8%</font>) CEO Andrew Mackenzie in Barcelona to discuss potential strategic changes at the mining company was \"<a href=\"http://www.reuters.com/article/us-bhp-billiton-elliott-idUSKCN18E004\" target=\"_blank\">constructive</a>.\"</li>     <li>Elliott says it had a private meeting with Mackenzie but does not provide further details; it was the first time BHP had met with Elliott since the fund went public with a $46B overhaul proposal on April 10.</li>     <li>Elliott is about <a href=\"http://www.reuters.com/article/us-column-russell-bhp-elliott-idUSKCN18E14S\" target=\"_blank\">half way to achieving its goal</a> of extracting better returns out of BHP simply by putting pressure on the company's management and board to do more in the name of shareholder value, Reuters' Clyde Russell writes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3268531\" data-linked=\"Elliott calls Barcelona meeting with BHP &quot;constructive&quot;\" data-tweet=\"$BHP - Elliott calls Barcelona meeting with BHP &quot;constructive&quot; https://seekingalpha.com/news/3268531-elliott-calls-barcelona-meeting-bhp-constructive?source=tweet\" data-url=\"https://seekingalpha.com/news/3268531-elliott-calls-barcelona-meeting-bhp-constructive\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268526\" data-ts=\"1495121328\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CUR\" target=\"_blank\">CUR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268526-neuralstem-completes-dosing-in-mid-stage-study-of-nsiminus-189-in-mdd-shares-ahead-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neuralstem completes dosing in mid-stage study of NSI-189 in MDD; shares ahead 6%</a></h4><ul><li>Neuralstem (<a href='https://seekingalpha.com/symbol/CUR' title='Neuralstem, Inc.'>CUR</a> <font color='green'>+6%</font>) <a href=\"https://seekingalpha.com/pr/16836630-neuralstem-reports-last-subject-phase-2-trial-nsiminus-189-major-depressive-disorder\" target=\"_blank\">completes dosing</a> in its 220-subject <a href=\"https://clinicaltrials.gov/ct2/show/NCT02695472?term=nsi-189&amp;cond=major+depressive+disorder&amp;rank=1\" target=\"_blank\">Phase 2 </a>clinical trial assessing NSI-189 for the treatment of major depressive disorder &#40;MDD&#41;. The study is 80% powered (p =&lt; 0.05) to show an improvement in depression symptoms versus placebo. Top-line data should be available in Q3.</li><li>The company says small molecule NSI-189 stimulates neurogenesis, synaptogenesis and increases hippocampal volume, all of which play a role in reversing depression, enhancing cognition and promoting the growth of new nerve tissue.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3244100-neuralstem-completes-enrollment-mid-stage-study-nsiminus-189-mdd-shares-ahead-19-percent\" target=\"_blank\">Neuralstem completes enrollment in mid-stage study of NSI-189 in MDD; shares ahead 19%</a> (Feb. 16)</li></ul><div class=\"tiny-share-widget\" data-id=\"3268526\" data-linked=\"Neuralstem completes dosing in mid-stage study of NSI-189 in MDD; shares ahead 6%\" data-tweet=\"$CUR $SNCA - Neuralstem completes dosing in mid-stage study of NSI-189 in MDD; shares ahead 6% https://seekingalpha.com/news/3268526-neuralstem-completes-dosing-in-mid-stage-study-of-nsiminus-189-in-mdd-shares-ahead-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3268526-neuralstem-completes-dosing-in-mid-stage-study-of-nsiminus-189-in-mdd-shares-ahead-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268525\" data-ts=\"1495121135\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TK\" target=\"_blank\">TK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268525-teekay-corpminus-10-teekay-offshoreminus-9-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teekay Corp. -10%, Teekay Offshore -9% after earnings</a></h4><ul><li>Teekay Corp. (<a href='https://seekingalpha.com/symbol/TK' title='Teekay Corporation'>TK</a> <font color='red'>-9.9%</font>) and Teekay Offshore Partners (<a href='https://seekingalpha.com/symbol/TOO' title='Teekay Offshore Partners L.P.'>TOO</a> <font color='red'>-8.8%</font>) are sharply lower after reporting Q1 earnings results and the cancellation of a contract with Petrobras (<a href='https://seekingalpha.com/symbol/PBR' title='Petrobras - Petroleo Brasileiro S.A.'>PBR</a> <font color='red'>-14.6%</font>).</li><li>TK reports a <a href=\"https://seekingalpha.com/news/3268336-teekay-reports-q1-results\" target=\"_blank\">Q1 loss</a> of $0.41/share on 15% lower revenues Y/Y of $543.5M, and TOO comes in with <a href=\"https://seekingalpha.com/news/3268335-teekay-offshore-partners-beats-revenue\" target=\"_blank\">Q1 earnings</a> of $0.10/share on 10% lower revenues of $276M.</li><li>TOO says it is disputing the grounds for PBR's termination of the <em>Arendal Spirit</em> UMS charter contract and is reviewing its legal options.</li><li>However, Teekay Tankers (<a href='https://seekingalpha.com/symbol/TNK' title='Teekay Tankers Ltd'>TNK</a> <font color='green'>+1.8%</font>) is higher after missing <a href=\"https://seekingalpha.com/news/3268334-teekay-tankers-misses-0_01-beats-revenue\" target=\"_blank\">Q1 earnings</a> estimates but posting better than expected revenue of $125M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3268525\" data-linked=\"Teekay Corp. -10%, Teekay Offshore -9% after earnings\" data-tweet=\"$TK $TK $TOO - Teekay Corp. -10%, Teekay Offshore -9% after earnings https://seekingalpha.com/news/3268525-teekay-corpminus-10-teekay-offshoreminus-9-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3268525-teekay-corpminus-10-teekay-offshoreminus-9-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268524\" data-ts=\"1495120999\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FXCOF\" target=\"_blank\">FXCOF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268524-japanese-fund-building-cash-in-possible-toshiba-bid-prep\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Japanese fund building cash in possible Toshiba bid prep</a></h4><ul>   <li>State-backed fund the Innovation Network Corp. of Japan will sell a stake in Renesas Electronics (<a href=\"http://seekingalpha.com/symbol/RNECY\" target=\"_blank\">RNECY</a> <font color='red'>-4.9%</font>) worth about $2.7B in what observers see as a sign that it's <a href=\"http://www.reuters.com/article/us-renesas-equity-sale-idUSKCN18E149?feedType=nl&amp;feedName=innovationNews&amp;utm_source=Sailthru&amp;utm_medium=email&amp;utm_campaign=US%20Deals%20Today%202017-05-18&amp;utm_term=US%20Deals%20Today\" target=\"_blank\">readying an investment</a> in the chip unit at Toshiba (<a href=\"http://seekingalpha.com/symbol/TOSYY\" target=\"_blank\">TOSYY</a> <font color='red'>-0.3%</font>).</li>    <li>That would likely be part of a consortium with another suitor that would have a key advantage over others -- including Foxconn (<a href='https://seekingalpha.com/symbol/FXCOF' title='FOXCONN TECH CO LTD ORD'>OTC:FXCOF</a>, <a href='https://seekingalpha.com/symbol/HNHAF' title='Hon Hai Precision Industry Co. Ltd.'>OTCPK:HNHAF</a>), Broadcom (<a href=\"http://seekingalpha.com/symbol/AVGO\" target=\"_blank\">AVGO</a> <font color='green'>+2.5%</font>) and Western Digital (<a href=\"http://seekingalpha.com/symbol/WDC\" target=\"_blank\">WDC</a> <font color='green'>+0.7%</font>) -- as it would keep important semiconductor technology inside Japan.</li>    <li>INCJ has been considering a partial exit of its Renesas stake for a couple of years, but funding would be timely as bidders compete over a unit that Toshiba values at &yen;2T (about $18B).</li>    <li>INCJ has just &yen;1T for acquisitions and investment, and so is cautious about making large-scale deals.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3268524\" data-linked=\"Japanese fund building cash in possible Toshiba bid prep\" data-tweet=\"$FXCOF $FXCOF $HNHAF - Japanese fund building cash in possible Toshiba bid prep https://seekingalpha.com/news/3268524-japanese-fund-building-cash-in-possible-toshiba-bid-prep?source=tweet\" data-url=\"https://seekingalpha.com/news/3268524-japanese-fund-building-cash-in-possible-toshiba-bid-prep\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268518\" data-ts=\"1495120505\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACHN\" target=\"_blank\">ACHN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268518-leerink-likes-achillion-sees-36-upside-shares-ahead-13\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Leerink likes Achillion, sees 36% upside; shares ahead 13%</a></h4><ul><li>Achillion Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ACHN' title='Achillion Pharmaceuticals, Inc.'>ACHN</a> <font color='green'>+12.7%</font>) is up on double normal volume on the heels of an upgrade to Outperform with a $6 (36% upside) price target by Leerink.</li><li>Analyst Joseph Schwartz says the company offers an attractive risk/reward opportunity at current levels with limited downside risk, assuming the J&amp;J HCV partnership remains intact.</li><li>Source: StreetInsider</li></ul><div class=\"tiny-share-widget\" data-id=\"3268518\" data-linked=\"Leerink likes Achillion, sees 36% upside; shares ahead 13%\" data-tweet=\"$ACHN - Leerink likes Achillion, sees 36% upside; shares ahead 13% https://seekingalpha.com/news/3268518-leerink-likes-achillion-sees-36-upside-shares-ahead-13?source=tweet\" data-url=\"https://seekingalpha.com/news/3268518-leerink-likes-achillion-sees-36-upside-shares-ahead-13\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268516\" data-ts=\"1495119923\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABEV\" target=\"_blank\">ABEV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268516-brazil-turmoil-hits-consumer-products-sellers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brazil turmoil hits consumer products sellers</a></h4><ul> <li>The political tumroil in Brazil is hitting a large number of consumer goods stocks with varying degrees of business interests in the region.</li> <li>Notable decliners include Ambev (<a href='https://seekingalpha.com/symbol/ABEV' title='Ambev - Companhia de Bebidas das Americas'>ABEV</a> <font color='red'>-10.8%</font>), BRF (<a href='https://seekingalpha.com/symbol/BRFS' title='BRF-Brasil Foods S.A.'>BRFS</a> <font color='red'>-7.6%</font>), Avon Products (<a href='https://seekingalpha.com/symbol/AVP' title='Avon Products, Inc.'>AVP</a> <font color='red'>-6.2%</font>), Tupperware Brands (<a href='https://seekingalpha.com/symbol/TUP' title='Tupperware Brands Corporation'>TUP</a> <font color='red'>-3.4%</font>), Anheuser-Busch InBev (<a href='https://seekingalpha.com/symbol/BUD' title='Anheuser-Busch InBev SA/NV'>BUD</a> <font color='red'>-2.7%</font>), Revlon (<a href='https://seekingalpha.com/symbol/REV' title='Revlon, Inc.'>REV</a> <font color='red'>-2.3%</font>), Colgate-Palmolive (<a href='https://seekingalpha.com/symbol/CL' title='Colgate-Palmolive Co.'>CL</a> <font color='red'>-1.7%</font>), Inter Parfums (<a href='https://seekingalpha.com/symbol/IPAR' title='Inter Parfums, Inc.'>IPAR</a> <font color='red'>-1.2%</font>) and Mattel (<a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a> <font color='red'>-0.7%</font>).</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3268439-brazil-crashes-new-political-scandal-bovespa-10-percent\" target=\"_blank\">Brazil crashes on new political scandal; Bovespa down more than 10%</a> (May 18)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3268478-nowhere-hide-meli-arco-amid-brazil-political-chaos\" target=\"_blank\">Nowhere to hide for MELI and ARCO amid Brazil political chaos</a> (May 18)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3268516\" data-linked=\"Brazil turmoil hits consumer products sellers\" data-tweet=\"$ABEV $ABEV $BRFS - Brazil turmoil hits consumer products sellers https://seekingalpha.com/news/3268516-brazil-turmoil-hits-consumer-products-sellers?source=tweet\" data-url=\"https://seekingalpha.com/news/3268516-brazil-turmoil-hits-consumer-products-sellers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268486\" data-ts=\"1495119663\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268486-healthcare-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GLYC' title='GlycoMimetics'>GLYC</a> <font color='green'>+66%</font>. <a href='https://seekingalpha.com/symbol/ACHN' title='Achillion Pharmaceuticals, Inc.'>ACHN</a> <font color='green'>+16%</font>. ETRM <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/BDSI' title='BioDelivery Sciences International, Inc.'>BDSI</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ELGX' title='Endologix Inc'>ELGX</a> <font color='red'>-34%</font>. <a href='https://seekingalpha.com/symbol/MBVX' title='MABVAX THERAPEUTICS HLDGS'>OTCPK:MBVX</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/NLNK' title='NewLink Genetics Corporation'>NLNK</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/QHC' title='Quorum Health Corporation'>QHC</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/SVA' title='Sinovac Biotech, Ltd.'>SVA</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3268486\" data-linked=\"Healthcare Gainers / Losers as of 11:00 am\" data-tweet=\"$GLYC $ACHN $RSLS - Healthcare Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3268486-healthcare-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3268486-healthcare-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268513\" data-ts=\"1495119403\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ULTA\" target=\"_blank\">ULTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268513-cleveland-research-positive-on-ulta-beauty\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cleveland Research positive on Ulta Beauty</a></h4><ul> <li>Cleveland Research raises its estimates on Ulta Beauty (<a href='https://seekingalpha.com/symbol/ULTA' title='Ulta Beauty, Inc.'>ULTA</a> <font color='green'>+0.7%</font>) to above the consensus marks.</li> <li>The boutique firms <a href=\"https://thefly.com/landingPageNews.php?id=2554665&amp;headline=ULTA-Ulta-Beauty-estimates-raised-above-consensus-at-Cleveland-Research\" target=\"_blank\">notes</a> that Ulta is lapping some extra supply chain spending from last year.</li> <li>Shares of Ulta Beauty are up 15% YTD and topped out at $301.40 earlier this month.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3268513\" data-linked=\"Cleveland Research positive on Ulta Beauty\" data-tweet=\"$ULTA - Cleveland Research positive on Ulta Beauty https://seekingalpha.com/news/3268513-cleveland-research-positive-on-ulta-beauty?source=tweet\" data-url=\"https://seekingalpha.com/news/3268513-cleveland-research-positive-on-ulta-beauty\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268512\" data-ts=\"1495119277\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHPG\" target=\"_blank\">SHPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268512-shires-madcamminus-1-antibody-successful-in-mid-stage-uc-study-shares-up-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shire&#39;s MAdCAM-1 antibody successful in mid-stage UC study; shares up 4%</a></h4><ul><li>A Phase 2 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT01620255?term=NCT01620255&amp;rank=1\" target=\"_blank\">TURANDOT</a>, assessing Shire's (<a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a> <font color='green'>+3.5%</font>) anti-mucosal addressin cell adhesion molecule 1 (MAdCAM-1) for the treatment of adult patients with moderate-to-severe ulcerative colitis &#40;UC&#41; <a href=\"https://seekingalpha.com/pr/16837541-lancet-publishes-phase-2-results-shires-investigational-anti-madcam-antibody-showing\" target=\"_blank\">met its primary endpoint</a> and secondary endpoints. The results were just <a href=\"http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2817%2930930-3/fulltext\" target=\"_blank\">published </a>in <em>The Lancet</em>.</li><li>At week 12, 16.7% of patients receiving 22.5 mg of MAdCAM-1 achieved remission as did 15.5% who received 75 mg. The rates were significantly greater than placebo in three of the four arms.</li><li>Discontinuations due to treatment-emergent adverse events were less than 5% . There was one death due to adenocarcinoma of the colon which was unlikely to be related to the study drug according to the data monitoring committee.</li><li>A Phase 3 study should commence next quarter.</li><li>Shire licensed MAdCAM-1 from Pfizer about a year ago.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3188744-shire-licenses-ibd-candidate-pfizer\" target=\"_blank\">Shire licenses IBD candidate from Pfizer</a> (June 14, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3268512\" data-linked=\"Shire&#39;s MAdCAM-1 antibody successful in mid-stage UC study; shares up 4%\" data-tweet=\"$SHPG - Shire&#39;s MAdCAM-1 antibody successful in mid-stage UC study; shares up 4% https://seekingalpha.com/news/3268512-shires-madcamminus-1-antibody-successful-in-mid-stage-uc-study-shares-up-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3268512-shires-madcamminus-1-antibody-successful-in-mid-stage-uc-study-shares-up-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268509\" data-ts=\"1495119159\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STMP\" target=\"_blank\">STMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268509-stamps-com-on-watch-after-seeking-alpha-article-circulated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stamps.com on watch after Seeking Alpha article circulated</a></h4><ul> <li>Stamps.com (NASDAQ:<a href='https://seekingalpha.com/symbol/STMP' title='Stamps.com Inc.'>STMP</a>) is <font color='red'>down 1.33%</font> on moderate volume to cut into the gains piled up over the last ten days.</li> <li>A new <a href=\"https://seekingalpha.com/article/4074232-management-covering-looming-changes-stamps-coms-ability-monetize-postage\" target=\"_blank\">article</a> from Seeking Alpha contributor The Friendly Bear is drawing some attention.</li> <li>If a defense on Stamps.com comes in from Wall Street, it will likely be from B. Riley, which named the stock one of its top picks of 2017 and reiterated a Buy rating on May 7.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3268509\" data-linked=\"Stamps.com on watch after Seeking Alpha article circulated\" data-tweet=\"$STMP - Stamps.com on watch after Seeking Alpha article circulated https://seekingalpha.com/news/3268509-stamps-com-on-watch-after-seeking-alpha-article-circulated?source=tweet\" data-url=\"https://seekingalpha.com/news/3268509-stamps-com-on-watch-after-seeking-alpha-article-circulated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268506\" data-ts=\"1495118411\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JACK\" target=\"_blank\">JACK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268506-caution-in-air-on-jack-in-box\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Caution in the air on Jack In The Box</a></h4><ul> <li>Telsey lowers its rating on Jack In The Box (NASDAQ:<a href='https://seekingalpha.com/symbol/JACK' title='Jack In The Box Inc.'>JACK</a>) to Market Perform from Outperform.</li> <li>KeyBanc moves to a Sector Weight rating from Overweight.</li> <li>Cowen stays with a Market Perform rating on Jack as it raises concerns over the level of discounting from the restaurant chain.</li> <li>Shares of Jack In The Box are <font color='red'>down 1.57%</font> to cut into yesterday's strong post-earnings rally.</li> <li>Sources: Bloomberg and Marketbeat.com</li></ul><div class=\"tiny-share-widget\" data-id=\"3268506\" data-linked=\"Caution in the air on Jack In The Box\" data-tweet=\"$JACK - Caution in the air on Jack In The Box https://seekingalpha.com/news/3268506-caution-in-air-on-jack-in-box?source=tweet\" data-url=\"https://seekingalpha.com/news/3268506-caution-in-air-on-jack-in-box\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268501\" data-ts=\"1495117955\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KR\" target=\"_blank\">KR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268501-grocery-store-stocks-gain-after-favorable-wal-mart-read-on-prices\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Grocery store stocks gain after favorable Wal-Mart read on prices</a></h4><ul> <li>Kroger (NYSE:<a href='https://seekingalpha.com/symbol/KR' title='Kroger Co.'>KR</a>) is <font color='green'>up 1.43%</font> and Supervalu (NYSE:<a href='https://seekingalpha.com/symbol/SVU' title='SUPERVALU Inc.'>SVU</a>) is <font color='green'>1.34% higher</font> to outpace broad market averages.</li> <li>The gains could be tied to comments from Wal-Mart CFO Brett Biggs that it saw flat food deflation in Q1. The grocery store sector has been reeling from lower prices on a wide assortment of products amid increased competition.</li> <li>Also showing some traction, Target (NYSE:<a href='https://seekingalpha.com/symbol/TGT' title='Target Corporation'>TGT</a>) is&nbsp;<font color='green'>up 1.20%</font>&nbsp;on the day as investors view the Wal-Mart numbers favorably.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3268383-wal-mart-beats-0_04-misses-revenue\" target=\"_blank\">Wal-Mart beats by $0.04, misses on revenue</a> (May 18)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3268391-solid-results-wal-mart-u-s\" target=\"_blank\">Solid results for Wal-Mart in the U.S.</a> (May 18)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3268501\" data-linked=\"Grocery store stocks gain after favorable Wal-Mart read on prices\" data-tweet=\"$KR $KR $SVU - Grocery store stocks gain after favorable Wal-Mart read on prices https://seekingalpha.com/news/3268501-grocery-store-stocks-gain-after-favorable-wal-mart-read-on-prices?source=tweet\" data-url=\"https://seekingalpha.com/news/3268501-grocery-store-stocks-gain-after-favorable-wal-mart-read-on-prices\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268498\" data-ts=\"1495117818\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268498-natural-gas-inventory-builds-slightly-expected\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas inventory builds slightly more than expected</a></h4><ul>     <li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory</a>: <strong>+68</strong>&nbsp;Bcf vs. +61 Bcf consensus, +45 Bcf last week.</li>     <li>Futures&nbsp;<font color='red'>-0.13%</font>&nbsp;to&nbsp;<font color='red'>$3.188</font>.</li>     <li>ETFs: <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/GAZ' title='iPath DJ-UBS Natural Gas Total Return Sub-Index ETN'>GAZ</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a>,<a href='https://seekingalpha.com/symbol/DCNG' title='iPath Pure Beta Seasonal Natural Gas ETN'>DCNG</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3268498\" data-linked=\"Natural gas inventory builds slightly more than expected\" data-tweet=\"$UNG $DGAZ $UGAZ - Natural gas inventory builds slightly more than expected https://seekingalpha.com/news/3268498-natural-gas-inventory-builds-slightly-expected?source=tweet\" data-url=\"https://seekingalpha.com/news/3268498-natural-gas-inventory-builds-slightly-expected\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268496\" data-ts=\"1495117168\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DFFN\" target=\"_blank\">DFFN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268496-diffusion-pharma-nabs-european-patent-covering-lead-product-candidate-trans-sodium\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Diffusion Pharma nabs European patent covering lead product candidate trans sodium crocetinate; shares ahead 11%</a></h4><ul><li>Thinly traded nano cap Diffusion Pharmaceuticals (<a href='https://seekingalpha.com/symbol/DFFN' title='Diffusion Pharmaceuticals Inc.'>DFFN</a> <font color='green'>+10.6%</font>) heads north on double normal volume in response to a <a href=\"https://register.epo.org/application?number=EP11790107\" target=\"_blank\">patent </a>to be issued by the European Patent Office protecting lead product candidate trans sodium crocetinate, currently being evaluated in a <a href=\"https://clinicaltrials.gov/ct2/show/NCT01465347?term=trans+sodium+crocetinate&amp;rank=2\" target=\"_blank\">Phase 1/2 study</a> in newly diagnosed glioblastoma.</li></ul><div class=\"tiny-share-widget\" data-id=\"3268496\" data-linked=\"Diffusion Pharma nabs European patent covering lead product candidate trans sodium crocetinate; shares ahead 11%\" data-tweet=\"$DFFN - Diffusion Pharma nabs European patent covering lead product candidate trans sodium crocetinate; shares ahead 11% https://seekingalpha.com/news/3268496-diffusion-pharma-nabs-european-patent-covering-lead-product-candidate-trans-sodium?source=tweet\" data-url=\"https://seekingalpha.com/news/3268496-diffusion-pharma-nabs-european-patent-covering-lead-product-candidate-trans-sodium\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268494\" data-ts=\"1495116838\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GFASY\" target=\"_blank\">GFASY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268494-gafisa-on-move\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gafisa on the move</a></h4><ul><li>Gafisa (GFA) moves deep into the red, <font color='red'>sinking almost 12%</font> in early trade.</li></ul><div class=\"tiny-share-widget\" data-id=\"3268494\" data-linked=\"Gafisa on the move\" data-tweet=\"$GFASY - Gafisa on the move https://seekingalpha.com/news/3268494-gafisa-on-move?source=tweet\" data-url=\"https://seekingalpha.com/news/3268494-gafisa-on-move\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268485\" data-ts=\"1495116072\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSCO\" target=\"_blank\">CSCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268485-ciscominus-7_5-after-guidance-dampens-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cisco -7.5% after guidance dampens expectations</a></h4><ul>   <li>After postmarket declines following <a href=\"https://seekingalpha.com/news/3268243-cisco-minus-4_8-percent-current-quarter-guidance-disappoints\" target=\"_blank\">yesterday's earnings</a>, Cisco Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CSCO' title='Cisco Systems, Inc.'>CSCO</a>) is <font color='red'>7.5% lower</font> this morning on the weak guidance provided.</li>    <li>Federal spending is a drag on expectations, of up to 1%, says JPMorgan's Rod Hall -- though he expects that could pick up as more empty slots are filled in the Trump administration.</li>    <li>He's Neutral on the stock, while Citi's Jim Suva sees a buying opportunity. He says the guidance is bad for electronics manufacturers with exposure to Cisco, notably Celestica (<a href=\"http://seekingalpha.com/symbol/CLS\" target=\"_blank\">CLS</a> <font color='red'>-2.5%</font>), Jabil Circuit (<a href=\"http://seekingalpha.com/symbol/JBL\" target=\"_blank\">JBL</a> <font color='red'>-3.4%</font>), Sanmina (<a href=\"http://seekingalpha.com/symbol/SANM\" target=\"_blank\">SANM</a> <font color='red'>-0.7%</font>) and Flex (<a href=\"http://seekingalpha.com/symbol/FLEX\" target=\"_blank\">FLEX</a> <font color='red'>-0.9%</font>).</li>    <li>RBC Capital's Mitch Steves is sticking with Outperform as well (though at a price target trimmed to $36 from $37). The stock will be in the \"penalty box\" until more details on long-term revenue growth come out at the company's analyst day in June, he says.</li>    <li>Networking peers are also lower this morning: <a href='https://seekingalpha.com/symbol/ANET' title='Arista Networks, Inc.'>ANET</a> <font color='red'>-0.7%</font>; <a href='https://seekingalpha.com/symbol/UBNT' title='Ubiquiti Networks, Inc.'>UBNT</a> <font color='red'>-0.5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3268485\" data-linked=\"Cisco -7.5% after guidance dampens expectations\" data-tweet=\"$CSCO $CSCO $ANET - Cisco -7.5% after guidance dampens expectations https://seekingalpha.com/news/3268485-ciscominus-7_5-after-guidance-dampens-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/3268485-ciscominus-7_5-after-guidance-dampens-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268481\" data-ts=\"1495115897\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMRT\" target=\"_blank\">SMRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268481-crushing-drop-for-stein-mart-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crushing drop for Stein Mart after earnings</a></h4><ul> <li>Stein Mart (NASDAQ:<a href='https://seekingalpha.com/symbol/SMRT' title='Stein Mart, Inc.'>SMRT</a>) is <font color='red'>down 38%</font> after posting an alarming Q1 report.</li> <li>\"We continue to experience softer-than-planned store traffic and sales,\" says Stein Mart CEO Hunt Hawkins. \"As a result, markdowns were significantly higher for the quarter despite our focus on inventory management,\" he adds.</li> <li>Comparable sales fell 7.6% Y/Y during the quarter.</li> <li>The company announced that it is suspending its quarterly dividend payout.</li> <li>Shares of Stein Mart traded as low as $1.01 today, compared to its 52-week high of $9.23.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3268234-stein-mart-misses-0_11-misses-revenue\" target=\"_blank\">Stein Mart misses by $0.11, misses on revenue</a> (May 17)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3268481\" data-linked=\"Crushing drop for Stein Mart after earnings\" data-tweet=\"$SMRT - Crushing drop for Stein Mart after earnings https://seekingalpha.com/news/3268481-crushing-drop-for-stein-mart-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3268481-crushing-drop-for-stein-mart-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268474\" data-ts=\"1495115514\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYTR\" target=\"_blank\">CYTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268474-late-stage-data-on-cytrxs-aldoxorubicin-in-sts-showed-treatment-benefit-shares-up-14\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Late-stage data on CytRx&#39;s aldoxorubicin in STS showed treatment benefit; shares up 14%</a></h4><ul><li>CytRx (<a href='https://seekingalpha.com/symbol/CYTR' title='CytRx Corporation'>CYTR</a> <font color='green'>+14.2%</font>) jumps out of the blocks this morning on the heels of its <a href=\"https://seekingalpha.com/pr/16836775-cytrx-present-global-phase-3-aldoxorubicin-clinical-data-patients-soft-tissue-sarcomas-2017\" target=\"_blank\">announcement </a>that Phase 3 data on aldoxorubicin in treatment-resistant soft tissue sarcoma &#40;STS&#41; will be presented on Friday afternoon, June 2, at ASCO.</li><li>In a summary released yesterday evening, patients treated with aldoxorubicin experienced median progression-free survival of 5.32 months compared to 2.96 months for investigator's choice therapy, a statistically significant difference (p=0.007) with a 38% reduction in the risk of tumor progression (hazard ratio = 0.62).</li><li>On the safety front, aldoxorubicin caused no clinically significant cardiac, renal or hepatic toxicities and showed no cardiotoxicity up to 40 cycles at a dose of 350 mg/m2&nbsp;per cycle. Left ventricular ejection fraction below 50% of expected values was reported in 4.2% of the aldoxorubicin group compared to 19.1% for investigator's choice.</li><li>#ASCO17</li></ul><div class=\"tiny-share-widget\" data-id=\"3268474\" data-linked=\"Late-stage data on CytRx&#39;s aldoxorubicin in STS showed treatment benefit; shares up 14%\" data-tweet=\"$CYTR - Late-stage data on CytRx&#39;s aldoxorubicin in STS showed treatment benefit; shares up 14% https://seekingalpha.com/news/3268474-late-stage-data-on-cytrxs-aldoxorubicin-in-sts-showed-treatment-benefit-shares-up-14?source=tweet\" data-url=\"https://seekingalpha.com/news/3268474-late-stage-data-on-cytrxs-aldoxorubicin-in-sts-showed-treatment-benefit-shares-up-14\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268478\" data-ts=\"1495115304\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MELI\" target=\"_blank\">MELI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268478-nowhere-to-hide-for-meli-and-arco-amid-brazil-political-chaos\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nowhere to hide for MELI and ARCO amid Brazil political chaos</a></h4><ul> <li>A couple of consumer stocks getting hit hard by the turmoil in Brazil are MercadoLibre (NASDAQ:<a href='https://seekingalpha.com/symbol/MELI' title='MercadoLibre, Inc.'>MELI</a>) and Arcos Dorados (NYSE:<a href='https://seekingalpha.com/symbol/ARCO' title='Arcos Dorados'>ARCO</a>).</li> <li>Mercadolibre is <font color='red'>down 8.18%</font> and Arcos Dorados is <font color='red'>off 6.46%</font> amid a growing political scandal in the nation. The drops are lower than the <font color='red'>16% slide</font> in the iShares MSCI Brazil Capped ETF.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3268478\" data-linked=\"Nowhere to hide for MELI and ARCO amid Brazil political chaos\" data-tweet=\"$MELI $MELI $ARCO - Nowhere to hide for MELI and ARCO amid Brazil political chaos https://seekingalpha.com/news/3268478-nowhere-to-hide-for-meli-and-arco-amid-brazil-political-chaos?source=tweet\" data-url=\"https://seekingalpha.com/news/3268478-nowhere-to-hide-for-meli-and-arco-amid-brazil-political-chaos\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268465\" data-ts=\"1495113984\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RL\" target=\"_blank\">RL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268465-ralph-lauren-higher-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ralph Lauren higher after earnings</a></h4><ul> <li>Ralph Lauren (NYSE:<a href='https://seekingalpha.com/symbol/RL' title='Ralph Lauren Corporation'>RL</a>) trades higher after cruising past some beaten-down estimates on <a href=\"https://seekingalpha.com/pr/16837199-ralph-lauren-reports-fourth-quarter-full-year-fiscal-2017-results\" target=\"_blank\">FQ4 profit</a>.</li> <li>EPS of $0.89 topped the consensus estimate of $0.78 off a gross margin rate of 55.40% vs. 55.05% consensus. Adjusted operating expenses as a percentage of sales improved 160 bps during the quarter to 47.7%.</li> <li>Same-store sales dropped off 11% during the quarter. Ralph Lauren sees FQ1 revenue falling at a low double-digit pace.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3268419-ralph-lauren-beats-0_11-beats-revenue\" target=\"_blank\">Ralph Lauren beats by $0.11, beats on revenue</a> (May 18)</li> <li>RL <font color='green'>+2.41%</font> premarket to $74.50 (moving lower during the conference call)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3268465\" data-linked=\"Ralph Lauren higher after earnings\" data-tweet=\"$RL - Ralph Lauren higher after earnings https://seekingalpha.com/news/3268465-ralph-lauren-higher-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3268465-ralph-lauren-higher-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268463\" data-ts=\"1495113764\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INCY\" target=\"_blank\">INCY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268463-initial-data-from-phase-1-2-study-of-incytes-epacadostat-opdivo-to-be-presented-asco-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Initial data from Phase 1/2 study of Incyte&#39;s epacadostat + Opdivo to be presented at ASCO; shares ahead 8% premarket</a></h4><ul><li>Incyte (NASDAQ:<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a>) is up&nbsp;<font color='green'>8%</font>&nbsp;premarket on average volume in response to its <a href=\"https://seekingalpha.com/pr/16836774-first-data-combination-epacadostat-opdivo-nivolumab-will-highlighted-asco-2017\" target=\"_blank\">announcement </a>that Phase 1/2 data (<a href=\"https://clinicaltrials.gov/ct2/show/NCT02327078?term=NCT02327078&amp;rank=1\" target=\"_blank\">ECHO-204</a> trial) on IDO1 enzyme inhibitor epacadostat combined with Bristol-Myers Squibb's Opdivo (nivolumab) in four cancers (head and neck, melanoma, ovarian, colorectal) will be presented at ASCO. This will be the first data release on the efficacy of the combo.</li></ul><div class=\"tiny-share-widget\" data-id=\"3268463\" data-linked=\"Initial data from Phase 1/2 study of Incyte&#39;s epacadostat + Opdivo to be presented at ASCO; shares ahead 8% premarket\" data-tweet=\"$INCY - Initial data from Phase 1/2 study of Incyte&#39;s epacadostat + Opdivo to be presented at ASCO; shares ahead 8% premarket https://seekingalpha.com/news/3268463-initial-data-from-phase-1-2-study-of-incytes-epacadostat-opdivo-to-be-presented-asco-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3268463-initial-data-from-phase-1-2-study-of-incytes-epacadostat-opdivo-to-be-presented-asco-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268462\" data-ts=\"1495113688\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268462-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul><li><a href='https://seekingalpha.com/symbol/GLYC' title='GlycoMimetics'>GLYC</a> <font color='green'>+24%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3268305-glycomimetics-drug-candidate-gets-fda-breakthrough-therapy-designation\" target=\"_blank\">receiving&nbsp;</a>&nbsp;FDA breakthrough therapy designation.</li><li><a href='https://seekingalpha.com/symbol/ATHN' title='athenahealth, Inc.'>ATHN</a> <font color='green'>+17%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3268445-athenahealth-14-percent-premarket-elliott-stake\" target=\"_blank\">Elliott stake</a>.</li><li><a href='https://seekingalpha.com/symbol/PLCE' title='The Children&#39;s Place Retail Stores, Inc.'>PLCE</a> <font color='green'>+12%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3268382-childrens-place-retail-stores-beats-0_31-beats-revenue\" target=\"_blank\">result</a>.</li><li>ETRM +11% on <a href=\"https://seekingalpha.com/news/3268458-enteromedics-vblock-implanted-richmond-va-shares-ahead-13-percent-premarket\" target=\"_blank\">announcing</a>&nbsp;neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders.</li><li><a href='https://seekingalpha.com/symbol/SNDX' title='Syndax Pharmaceuticals, Inc.'>SNDX</a> <font color='green'>+10%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3268108-syndax-advances-study-etinostat-keytruda-shares-ahead-12-percent-premarket\" target=\"_blank\">advances study</a> of etinostat and Keytruda.</li><li><a href='https://seekingalpha.com/symbol/P' title='Pandora Media'>P</a> <font color='green'>+9%</font>.</li><li><a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a> <font color='green'>+8%</font>.</li><li><a href='https://seekingalpha.com/symbol/LB' title='L Brands, Inc.'>LB</a> <font color='green'>+6%.</font>on Q1 <a href=\"https://seekingalpha.com/news/3268259-l-brands-beats-0_04-revenue-line\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a> <font color='green'>+6%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/news/3268414-shires-lanadelumab-successful-late-stage-hae-study-shares-ahead-6-percent-premarket\" target=\"_blank\">announcement&nbsp;</a>of positive results from a Phase 3 clinical trial.</li><li><a href='https://seekingalpha.com/symbol/VSLR' title='Vivint Solar'>VSLR</a> <font color='green'>+5%</font>&nbsp;announcing a&nbsp;<a href=\"https://seekingalpha.com/pr/16837276-mercedes-benz-energy-vivint-solar-team-bring-automotive-battery-innovation-u-s-residential\" target=\"_blank\">collaboration</a>&nbsp;with Daimler (<a href='https://seekingalpha.com/symbol/DDAIF' title='Daimler AG'>OTCPK:DDAIF</a>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3268462\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$GLYC $ATHN $PLCE - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3268462-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3268462-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268460\" data-ts=\"1495113555\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268460-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/ASNA' title='Ascena Retail Group Inc'>ASNA</a>&nbsp;<font color='red'>-44%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3268272-ascena-plunges-32-percent-slashing-outlook\" target=\"_blank\">lower outlook</a>.</li><li><a href='https://seekingalpha.com/symbol/BBD' title='Banco Bradesco, S.A.'>BBD</a>&nbsp;<font color='red'>-20%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3268439-brazil-crashes-new-political-scandal-bovespa-10-percent\" target=\"_blank\">political scandal</a>.</li><li><a href='https://seekingalpha.com/symbol/GOL' title='GOL Linhas Areas Inteligentes S.A.'>GOL</a> <font color='red'>-19%</font>.</li><li><a href='https://seekingalpha.com/symbol/ITUB' title='Itau Unibanco Holding S.A.'>ITUB</a>&nbsp;<font color='red'>-19%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/news/3268439-brazil-crashes-new-political-scandal-bovespa-10-percent\" target=\"_blank\">political scandal</a>.</li><li><a href='https://seekingalpha.com/symbol/BSBR' title='Banco Santander &#40;Brasil&#41; S.A.'>BSBR</a>&nbsp;<font color='red'>-19%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/news/3268439-brazil-crashes-new-political-scandal-bovespa-10-percent\" target=\"_blank\">political scandal</a>.</li><li><a href='https://seekingalpha.com/symbol/PBR.A' title='Petrobras - Petrleo Brasileiro S.A.'>PBR.A</a> <font color='red'>-18%</font>.</li><li><a href='https://seekingalpha.com/symbol/PBR' title='Petrobras - Petroleo Brasileiro S.A.'>PBR</a>&nbsp;<font color='red'>-18%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/news/3268439-brazil-crashes-new-political-scandal-bovespa-10-percent\" target=\"_blank\">political scandal</a>.</li><li><a href='https://seekingalpha.com/symbol/ERJ' title='Embraer S.A.'>ERJ</a> <font color='red'>-16%</font>.</li><li><a href='https://seekingalpha.com/symbol/GGB' title='Gerdau S.A.'>GGB</a> <font color='red'>-15%</font>.</li><li><a href='https://seekingalpha.com/symbol/CIG' title='Companhia Energtica de Minas Gerais - CEMIG'>CIG</a> <font color='red'>-15%</font>.</li><li><a href='https://seekingalpha.com/symbol/VIV' title='Telefonica Brasil, S.A'>VIV</a> <font color='red'>-13%</font>.</li><li><a href='https://seekingalpha.com/symbol/ABEV' title='Ambev - Companhia de Bebidas das Americas'>ABEV</a> <font color='red'>-13%</font>.</li><li><a href='https://seekingalpha.com/symbol/SID' title='Companhia Siderurgica Nacional'>SID</a> <font color='red'>-13%</font>.</li><li><a href='https://seekingalpha.com/symbol/CZZ' title='Cosan Limited'>CZZ</a> <font color='red'>-13%</font>.</li><li><a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a>&nbsp;<font color='red'>-11%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/news/3268439-brazil-crashes-new-political-scandal-bovespa-10-percent\" target=\"_blank\">political scandal</a>.</li><li><a href='https://seekingalpha.com/symbol/CPL' title='CPFL Energia S.A.'>CPL</a> <font color='red'>-8%</font>.</li><li><a href='https://seekingalpha.com/symbol/MELI' title='MercadoLibre, Inc.'>MELI</a> <font color='red'>-8%</font>.</li><li><a href='https://seekingalpha.com/symbol/CSCO' title='Cisco Systems, Inc.'>CSCO</a>&nbsp;<font color='red'>-7%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3268233-cisco-beats-0_02-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/ZTO' title='ZTO Express'>ZTO</a>&nbsp;<font color='red'>-6%</font>&nbsp;<a href=\"https://seekingalpha.com/news/3268283-zto-express-beats-0_01-beats-revenue\" target=\"_blank\">on Q1 earnings</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3268460\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$ASNA $BBD $GOL - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3268460-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3268460-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268458\" data-ts=\"1495113187\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RSLS\" target=\"_blank\">RSLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268458-enteromedics-vblock-implanted-in-richmond-va-shares-ahead-13-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EnteroMedics&#39; vBlock implanted in Richmond VA; shares ahead 13% premarket</a></h4><ul><li>Nano cap EnteroMedics (ETRM) is poised to continue its rollercoaster price movement this morning. Shares are up&nbsp;<font color='green'>13%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16837094-enteromedics-announces-first-vbloc-neurometabolic-therapy-implant-mcguire-veterans-affairs\" target=\"_blank\">announcement </a>that the first vBloc Neurometabolic Therapy has been implanted at the VA Medical Center in Richmond, VA.</li><li>The company's Maestro vBloc is&nbsp;a pacemaker-like device that delivers vagal nerve blocking therapy via electrodes that are surgically implanted subcutaneously in the abdomen. The electrodes are placed in contact with the trunks of the vagus nerves just above the junction between the esophagus and the stomach. The device intermittently blocks vagal nerve signals throughout the patient's waking hours which produces the sensation of fullness.</li><li>In January, shares ballooned almost 15-fold on the news that two new medical centers had incorporated vBloc into their practices. Shares rallied almost 50% a few days ago ahead of its Q1 results, but made a round trip afterward.</li></ul><div class=\"tiny-share-widget\" data-id=\"3268458\" data-linked=\"EnteroMedics&#39; vBlock implanted in Richmond VA; shares ahead 13% premarket\" data-tweet=\"$RSLS - EnteroMedics&#39; vBlock implanted in Richmond VA; shares ahead 13% premarket https://seekingalpha.com/news/3268458-enteromedics-vblock-implanted-in-richmond-va-shares-ahead-13-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3268458-enteromedics-vblock-implanted-in-richmond-va-shares-ahead-13-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268455\" data-ts=\"1495112768\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSLR\" target=\"_blank\">FSLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268455-first-solarminus-1_7-on-baird-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Solar -1.7% on Baird downgrade</a></h4><ul><li>First Solar (NASDAQ:<a href='https://seekingalpha.com/symbol/FSLR' title='First Solar, Inc.'>FSLR</a>) <font color='red'>-1.7%</font>&nbsp;premarket after Baird <a href=\"https://www.streetinsider.com/Analyst+Comments/Baird+Downgrades+First+Solar+%28FSLR%29+to+Neutral/12919958.html\" target=\"_blank\">downgrades</a> shares to Neutral from Outperform with a $38 price target, citing valuation.</li><li>FSLR rose ~28% over the past month, driven by execution toward Series 6 production, selling of Series 4  inventory, and potential for tariffs to be applied on foreign cell  imports by the U.S. ITC, but Baird believes tariffs would be detrimental to U.S. solar markets and expects trade groups to fight against them.</li><li>The firm says it seeks clarity on Series 6  margins or a better entry point before becoming more constructive on the stock.</li></ul><div class=\"tiny-share-widget\" data-id=\"3268455\" data-linked=\"First Solar -1.7% on Baird downgrade\" data-tweet=\"$FSLR - First Solar -1.7% on Baird downgrade https://seekingalpha.com/news/3268455-first-solarminus-1_7-on-baird-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3268455-first-solarminus-1_7-on-baird-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268446\" data-ts=\"1495111929\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLCO\" target=\"_blank\">MLCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268446-macau-casino-stocks-fall-back\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macau casino stocks fall back</a></h4><ul> <li>Cautious comments by Macau's Gaming Inspection and Coordination Bureau director Paulo Chan and a slighty light revenue forecast from Credit Suisse hit Macau casino stocks in Hong Kong earlier today and are now influencing the U.S.-traded names.</li> <li>Premarket decliners: Melco Resorts &amp; Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/MLCO' title='Melco Resorts & Entertainment Limited ADR'>MLCO</a>) <font color='red'>-4.09%</font>, MGM Resorts (NYSE:<a href='https://seekingalpha.com/symbol/MGM' title='MGM Resorts International'>MGM</a>) <font color='red'>-1.99%</font>, Las Vegas Sands (NYSE:<a href='https://seekingalpha.com/symbol/LVS' title='Las Vegas Sands Corp.'>LVS</a>) <font color='red'>-1.48%</font>, Wynn Resorts (NASDAQ:<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a>) <font color='red'>-2.1%</font>.</li> <li>Macau casino stocks: Wynn Macau (<a href='https://seekingalpha.com/symbol/WYNMF' title='Wynn Macau Ltd.'>OTCPK:WYNMF</a>, <a href='https://seekingalpha.com/symbol/WYNMY' title='Wynn Macau Ltd. ADR'>OTCPK:WYNMY</a>), Sands China (<a href='https://seekingalpha.com/symbol/SCHYY' title='Sands China Ltd ADR'>OTCPK:SCHYY</a>, <a href='https://seekingalpha.com/symbol/SCHYF' title='Sands China Ltd'>OTCPK:SCHYF</a>), MGM China (<a href='https://seekingalpha.com/symbol/MCHVF' title='MGM China Holdings, Ltd.'>OTCPK:MCHVF</a>, <a href='https://seekingalpha.com/symbol/MCHVY' title='MGM China Holdings, Ltd. ADR'>OTCPK:MCHVY</a>), Galaxy Entertainment (<a href='https://seekingalpha.com/symbol/GXYEF' title='Galaxy Entertainment Group, Ltd.'>OTCPK:GXYEF</a>), SJM Holdings (<a href='https://seekingalpha.com/symbol/SJMHF' title='SJM Holdings Ltd.'>OTCPK:SJMHF</a>, <a href='https://seekingalpha.com/symbol/SJMHY' title='SJM Holdings Ltd. ADR'>OTCPK:SJMHY</a>).</li>     <li>Related ETF: <a href='https://seekingalpha.com/symbol/BJK' title='VanEck Vectors Gaming ETF'>BJK</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3268446\" data-linked=\"Macau casino stocks fall back\" data-tweet=\"$MLCO $MLCO $MGM - Macau casino stocks fall back https://seekingalpha.com/news/3268446-macau-casino-stocks-fall-back?source=tweet\" data-url=\"https://seekingalpha.com/news/3268446-macau-casino-stocks-fall-back\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268445\" data-ts=\"1495111831\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATHN\" target=\"_blank\">ATHN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268445-athenahealth-up-14-premarket-on-elliott-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Athenahealth up 14% premarket on Elliott stake</a></h4><ul><li>Athenahealth (NASDAQ:<a href='https://seekingalpha.com/symbol/ATHN' title='athenahealth, Inc.'>ATHN</a>) is up&nbsp;<font color='green'>14%</font>&nbsp;premarket on average volume in apparent response to a <a href=\"https://www.sec.gov/Archives/edgar/data/904495/000101359417000394/athena13d-051817.htm\" target=\"_blank\">13D filing</a> by hedge fund manager Elliott Associates showing a 9.2% stake.</li><li>Elliott says the company is undervalued and has a disruptive value proposition.</li></ul><div class=\"tiny-share-widget\" data-id=\"3268445\" data-linked=\"Athenahealth up 14% premarket on Elliott stake\" data-tweet=\"$ATHN - Athenahealth up 14% premarket on Elliott stake https://seekingalpha.com/news/3268445-athenahealth-up-14-premarket-on-elliott-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3268445-athenahealth-up-14-premarket-on-elliott-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268442\" data-ts=\"1495111361\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VSLR\" target=\"_blank\">VSLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268442-vivint-solar-daimler-reach-deal-on-u-s-home-batteries\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vivint Solar, Daimler reach deal on U.S. home batteries</a></h4><ul>     <li>Vivint Solar (NYSE:<a href='https://seekingalpha.com/symbol/VSLR' title='Vivint Solar'>VSLR</a>)&nbsp;<font color='green'>+3.6%</font> premarket after announcing a <a href=\"https://seekingalpha.com/pr/16837276-mercedes-benz-energy-vivint-solar-team-bring-automotive-battery-innovation-u-s-residential\" target=\"_blank\">collaboration</a> with Daimler (<a href='https://seekingalpha.com/symbol/DDAIF' title='Daimler AG'>OTCPK:DDAIF</a>) to bring the Mercedes-Benz customizable home energy storage system to the U.S. residential solar market.</li>     <li>The exclusive partnership will mark VSLR's first foray into energy storage and Daimler's entry into the U.S. market for home batteries; the companies <a href=\"http://www.reuters.com/article/daimler-vivint-batteries-idUSL2N1IJ1OA\" target=\"_blank\">will compete against similar offerings</a> from the likes of Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>), Sunrun (NASDAQ:<a href='https://seekingalpha.com/symbol/RUN' title='Sunrun'>RUN</a>) and LG Chem (<a href='https://seekingalpha.com/symbol/LGCLF' title='LG Chemical Co., Ltd.'>OTCPK:LGCLF</a>).</li>     <li>Daimler will sell the batteries through its Mercedes-Benz Energy subsidiary established last year, bringing its brand to the home energy market in much the same way Tesla has with its Powerwall batteries.</li>     <li>The systems are available immediately, and VSLR plans to sell them both online and through its primary door-to-door sales operation.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3268442\" data-linked=\"Vivint Solar, Daimler reach deal on U.S. home batteries\" data-tweet=\"$VSLR $VSLR $DDAIF - Vivint Solar, Daimler reach deal on U.S. home batteries https://seekingalpha.com/news/3268442-vivint-solar-daimler-reach-deal-on-u-s-home-batteries?source=tweet\" data-url=\"https://seekingalpha.com/news/3268442-vivint-solar-daimler-reach-deal-on-u-s-home-batteries\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>112&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268440\" data-ts=\"1495111274\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BCRX\" target=\"_blank\">BCRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268440-shires-positive-data-for-hae-candidate-lanadelumab-pressures-biocryst-shares-down-6-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shire&#39;s positive data for HAE candidate lanadelumab pressures BioCryst; shares down 6% premarket</a></h4><ul><li>BioCryst Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/BCRX' title='BioCryst Pharmaceuticals, Inc.'>BCRX</a>) is down&nbsp;<font color='red'>6%</font>&nbsp;premarket on light volume in apparent response to Shire's successful Phase 3 results for hereditary angioedema &#40;HAE&#41; candidate lanadelumab.</li><li>BioCryst's HAE candidate is Phase 2-stage <a href=\"http://www.biocryst.com/pipeline-product/next-generation-kallikrein-inhibitors-hae\" target=\"_blank\">BCX7353</a>, also a kallikrein inhibitor.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3268414-shires-lanadelumab-successful-late-stage-hae-study-shares-ahead-6-percent-premarket\" target=\"_blank\">Shire's lanadelumab successful in late-stage HAE study; shares ahead 6% premarket</a> (May 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3268440\" data-linked=\"Shire&#39;s positive data for HAE candidate lanadelumab pressures BioCryst; shares down 6% premarket\" data-tweet=\"$BCRX - Shire&#39;s positive data for HAE candidate lanadelumab pressures BioCryst; shares down 6% premarket https://seekingalpha.com/news/3268440-shires-positive-data-for-hae-candidate-lanadelumab-pressures-biocryst-shares-down-6-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3268440-shires-positive-data-for-hae-candidate-lanadelumab-pressures-biocryst-shares-down-6-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268439\" data-ts=\"1495111164\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBR\" target=\"_blank\">PBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268439-brazil-crashes-on-new-political-scandal-bovespa-down-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brazil crashes on new political scandal; Bovespa down more than 10%</a></h4><ul><li>Reports that President Michel Temer <a href=\"https://seekingalpha.com/news/3268341-brazil-back-political-crisis\" target=\"_blank\">was caught on tape</a> discussing bribes has Bovespa futures<font color='red'> lower by more than 10%</font>, and the real (NYSEARCA:<a href='https://seekingalpha.com/symbol/BZF' title='WisdomTree Brazilian Real ETF'>BZF</a>)&nbsp;<font color='red'>down more than 6%</font>.</li><li>The iShares MSCI Brazil ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/EWZ' title='iShares MSCI Brazil Capped ETF'>EWZ</a>) is&nbsp;<font color='red'>down 17%</font>&nbsp;premarket.</li><li>Petrobas (NYSE:<a href='https://seekingalpha.com/symbol/PBR' title='Petrobras - Petroleo Brasileiro S.A.'>PBR</a>)&nbsp;<font color='red'>-18%</font>, <a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a>&nbsp;<font color='red'>-12%</font>, <a href='https://seekingalpha.com/symbol/BSBR' title='Banco Santander &#40;Brasil&#41; S.A.'>BSBR</a><font color='red'> -20%</font>, Itau Unibanco (NYSE:<a href='https://seekingalpha.com/symbol/ITUB' title='Itau Unibanco Holding S.A.'>ITUB</a>)&nbsp;<font color='red'>-18%</font>, Banco Bradesco (NYSE:<a href='https://seekingalpha.com/symbol/BBD' title='Banco Bradesco, S.A.'>BBD</a>)&nbsp;<font color='red'>-18%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3268439\" data-linked=\"Brazil crashes on new political scandal; Bovespa down more than 10%\" data-tweet=\"$PBR $BZF $EWZ - Brazil crashes on new political scandal; Bovespa down more than 10% https://seekingalpha.com/news/3268439-brazil-crashes-on-new-political-scandal-bovespa-down-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3268439-brazil-crashes-on-new-political-scandal-bovespa-down-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268428\" data-ts=\"1495110095\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHAK\" target=\"_blank\">SHAK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268428-shake-shack-gains-steam-after-wedbush-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shake Shack gains steam after Wedbush upgrade</a></h4><ul> <li>Wedbush Securities upgrades Shake Shack (NYSE:<a href='https://seekingalpha.com/symbol/SHAK' title='Shake Shack'>SHAK</a>) to Outperform from Neutral on its view that consensus EBITDA estimates may be topped as new Shak units outperform.</li> <li>The investment firm lifts its price target on Shake Shack to $43 from $33.</li> <li>SHAK <font color='green'>+1.77%</font> premarket to $37.30.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3268428\" data-linked=\"Shake Shack gains steam after Wedbush upgrade\" data-tweet=\"$SHAK - Shake Shack gains steam after Wedbush upgrade https://seekingalpha.com/news/3268428-shake-shack-gains-steam-after-wedbush-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3268428-shake-shack-gains-steam-after-wedbush-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268424\" data-ts=\"1495109454\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKE\" target=\"_blank\">BKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268424-buckle-cfo-to-retire\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buckle CFO to retire</a></h4><ul> <li>Buckle (NYSE:<a href='https://seekingalpha.com/symbol/BKE' title='The Buckle, Inc.'>BKE</a>) announces that&nbsp;CFO&nbsp;Karen Rhoads&nbsp;will retire from the company later this summer.</li><li>Rhoads&nbsp;plans to continue to serve on the board of directors.</li>     <li>Buckle says it engaged an executive search firm to assist       with the hunt for a new CFO, including&nbsp;reviewing       both internal and external candidates</li><li>BKE  <font color='red'>-3.87%</font> premarket to  $16.15 after reporting earnings earlier.</li><li>Source: <a href=\"https://seekingalpha.com/pr/16837096-buckle-inc-reports-first-quarter-net-income-announces-planned-retirement-senior-vice\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3268424\" data-linked=\"Buckle CFO to retire\" data-tweet=\"$BKE - Buckle CFO to retire https://seekingalpha.com/news/3268424-buckle-cfo-to-retire?source=tweet\" data-url=\"https://seekingalpha.com/news/3268424-buckle-cfo-to-retire\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268423\" data-ts=\"1495109437\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PGR\" target=\"_blank\">PGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268423-progressive-higher-after-strong-april\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Progressive higher after strong April</a></h4><ul><li><a href=\"http://investors.progressive.com/phoenix.zhtml?c=81824&amp;p=irol-newsArticle&amp;ID=2273546\" target=\"_blank\">Net premiums written</a> last month of $2.7B up 16% Y/Y; net premiums earned of $2.39B up 13%.</li><li>EPS of $0.34 up from $0.09 earned in April one year ago.</li><li>Combined ratio improves to 88.9 from 98.4.</li><li>Deutsche Bank pulls its Sell rating, upgrading to Hold.</li><li>There's no premarket action, but <a href='https://seekingalpha.com/symbol/PGR' title='Progressive Corporation'>PGR</a> was&nbsp;<font color='green'>higher by 6.9%</font>&nbsp;in modest after hours trade last night.</li></ul><div class=\"tiny-share-widget\" data-id=\"3268423\" data-linked=\"Progressive higher after strong April\" data-tweet=\"$PGR - Progressive higher after strong April https://seekingalpha.com/news/3268423-progressive-higher-after-strong-april?source=tweet\" data-url=\"https://seekingalpha.com/news/3268423-progressive-higher-after-strong-april\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268420\" data-ts=\"1495109054\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BONT\" target=\"_blank\">BONT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268420-on-bon-ton-stores-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Bon-Ton Stores&#39; Q1</a></h4><ul>     <li>The Bon-Ton Stores (NASDAQ:<a href='https://seekingalpha.com/symbol/BONT' title='The Bon-Ton Stores, Inc.'>OTC:BONT</a>)&nbsp;reports comparable-store sales declined 8.8% in <a href=\"https://seekingalpha.com/pr/16837046-bon-ton-stores-inc-reports-first-quarter-fiscal-2017-results\" target=\"_blank\">Q1</a>.</li><li>Proprietary credit card sales rate rose 90 bps to 55.8%.</li><li>Gross margin rate squeezed 170 bps to 32.2%.</li><li>SG&amp;A expense rate up 170 bps to 38.3%.</li><li>Merchandise inventories +0.2% to $713.73M.</li><li>Store count was 261 for the quarter.</li><li>The company ended the quarter with excess borrowing capacity of ~$226.5M&nbsp;under its revolving credit facility.</li><li><strong>FY2017 Guidance</strong>: Comparable sales: -3% to -4%; Gross margin rate: flat to +10 bps; SG&amp;A: $855M to $857M; Adjusted EBITDA: $115M to $125M; Diluted EPS: -$2.08 to -$2.59; Shares outstanding: $20.3M; Capex: not to exceed $30M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3268420\" data-linked=\"More on Bon-Ton Stores&#39; Q1\" data-tweet=\"$BONT - More on Bon-Ton Stores&#39; Q1 https://seekingalpha.com/news/3268420-on-bon-ton-stores-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3268420-on-bon-ton-stores-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268414\" data-ts=\"1495108691\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHPG\" target=\"_blank\">SHPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268414-shires-lanadelumab-successful-in-late-stage-hae-study-shares-ahead-6-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shire&#39;s lanadelumab successful in late-stage HAE study; shares ahead 6% premarket</a></h4><ul><li>Shire plc (NASDAQ:<a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a>) is up&nbsp;<font color='green'>6%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16837112-shires-investigational-treatment-lanadelumab-reduces-hereditary-angioedema-monthly-attack\" target=\"_blank\">announcement </a>of positive results from a Phase 3 clinical trial, HELP, assessing lanadelumab for the treatment of hereditary angioedema &#40;HAE&#41;, an inherited disorder characterized by recurrent swelling in the extremities, GI tract and upper airways.</li><li>The study met it s primary endpoint and all secondary endpoints. Patients receiving 300 mg of lanadelumab once every two weeks experienced a statistically significant reduction in average HAE attack frequency of 87% compared to placebo (p&lt;0.001). The trial was representative of the full HAE disease spectrum.</li><li>The company intends to file its U.S. marketing application in Q4 or Q1 2018. It has Orphan Drug and Breakthrough Therapy status in the U.S. and Orphan Drug status in the EU.</li><li>Lanadelumab is a human monoclonal antibody that binds to (inhibits) an enzyme called&nbsp;<a href=\"https://en.wikipedia.org/wiki/Plasma_kallikrein\" target=\"_blank\">plasma kallikrein</a>&nbsp;that plays a key role in blood pressure regulation, thrombosis and inflammation.</li></ul><div class=\"tiny-share-widget\" data-id=\"3268414\" data-linked=\"Shire&#39;s lanadelumab successful in late-stage HAE study; shares ahead 6% premarket\" data-tweet=\"$SHPG - Shire&#39;s lanadelumab successful in late-stage HAE study; shares ahead 6% premarket https://seekingalpha.com/news/3268414-shires-lanadelumab-successful-in-late-stage-hae-study-shares-ahead-6-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3268414-shires-lanadelumab-successful-in-late-stage-hae-study-shares-ahead-6-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268411\" data-ts=\"1495108317\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PERY\" target=\"_blank\">PERY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268411-on-perry-ellis-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Perry Ellis&#39; Q1</a></h4><ul><li>Perry Ellis (NASDAQ:<a href='https://seekingalpha.com/symbol/PERY' title='Perry Ellis International Inc.'>PERY</a>)&nbsp;reports revenue declined 6.5% on a constant currency basis in <a href=\"https://seekingalpha.com/pr/16837062-perry-ellis-international-reports-first-quarter-fiscal-2018-results\" target=\"_blank\">Q1</a>.</li><li>Royalty income dropped 20.7% to $8.27M for the quarter.</li><li>Adjusted gross margin rate improved 90 bps to 37.6%.</li><li>SG&amp;A expense rate up 260 bps to 29.4%.</li><li>Adjusted EBITDA margin rate fell 180 bps to 8.2%.</li><li><b>FY2018 Guidance</b>: Revenue: $870M to $880M; Adjusted EPS: $2.07 to $2.17.</li></ul><div class=\"tiny-share-widget\" data-id=\"3268411\" data-linked=\"More on Perry Ellis&#39; Q1\" data-tweet=\"$PERY - More on Perry Ellis&#39; Q1 https://seekingalpha.com/news/3268411-on-perry-ellis-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3268411-on-perry-ellis-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268409\" data-ts=\"1495108176\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLCE\" target=\"_blank\">PLCE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268409-childrens-placeplus-11-after-defying-retail-slump-in-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Children&#39;s Place +11% after defying retail slump in Q1</a></h4><ul> <li>The Children's Place (NASDAQ:<a href='https://seekingalpha.com/symbol/PLCE' title='The Children&#39;s Place Retail Stores, Inc.'>PLCE</a>) reports comparable sales ran 6.1% higher in <a href=\"https://seekingalpha.com/pr/16837114-children-s-place-reports-first-quarter-results\" target=\"_blank\">Q1</a> after analysts expected a mark of +2.1%.</li> <li>The sizzling (relative to retail) pace of comparable sales growth was The Children's Place highest for the quarter in more than a decade and came against a solid 5% gain last year.</li> <li>Adjusted gross profit fell 20 bps to 39.2% as a higher mix of e-commerce sales factored in. Adjusted operating income improved to 11.1% of sales vs. 9.4% a year ago.</li> <li>The company expects FY17 EPS of $7.10 to $7.20 vs. $6.66 consensus.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3268381-childrens-place-retail-stores-declares-0_40-dividend\" target=\"_blank\">Children's Place Retail Stores declares $0.40 dividend</a> (May 18)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3268382-childrens-place-retail-stores-beats-0_31-beats-revenue\" target=\"_blank\">Children's Place Retail Stores beats by $0.31, beats on revenue</a> (May 18)</li> <li>PLCE <font color='green'>+11.11%</font> premarket to $124.00. The 52-week high for PLCE is $125.30.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3268409\" data-linked=\"Children&#39;s Place +11% after defying retail slump in Q1\" data-tweet=\"$PLCE - Children&#39;s Place +11% after defying retail slump in Q1 https://seekingalpha.com/news/3268409-childrens-placeplus-11-after-defying-retail-slump-in-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3268409-childrens-placeplus-11-after-defying-retail-slump-in-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268393\" data-ts=\"1495106680\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BABA\" target=\"_blank\">BABA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268393-alibaba-down-1_7-after-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alibaba down 1.7% after earnings miss</a></h4><ul><li>FQ4 $5.6B up 60% Y/Y; core commerce revenue of $4.587B up 47%; cloud computing revenue of $314M up 103%; digital media and entertainment revenue of $571M up 234%; innovation initiatives and other revenue of $133M up 88%.</li><li>Annual active buyers on Chinese retail marketplaces of 454M up 11M from last quarter; mobile MAUs of 507M up 14M.</li><li>Number &nbsp;of paying customers on cloud business rose to 874K from 765K in Dec. quarter; adjusted EBITDA loss of $24M.</li><li>Non-GAAP free cash flow of $1.159B.</li><li>New $6B buyback program authorized - repurchases will mostly be to offset stock-based compensation.</li><li><a href=\"http://www.alibabagroup.com/en/ir/earnings\" target=\"_blank\">Conference call </a>at 7:30 ET</li><li>Previously: <a href=\"https://seekingalpha.com/news/3268378-alibaba-misses-0_02-beats-revenue\" target=\"_blank\">Alibaba misses by $0.02, beats on revenue</a> (May 18)</li><li><a href='https://seekingalpha.com/symbol/BABA' title='Alibaba Group Holding Limited'>BABA</a>&nbsp;<font color='red'>-1.7%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3268393\" data-linked=\"Alibaba down 1.7% after earnings miss\" data-tweet=\"$BABA - Alibaba down 1.7% after earnings miss https://seekingalpha.com/news/3268393-alibaba-down-1_7-after-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3268393-alibaba-down-1_7-after-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268391\" data-ts=\"1495106292\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WMT\" target=\"_blank\">WMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268391-solid-results-for-wal-mart-in-u-s\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Solid results for Wal-Mart in the U.S.</a></h4><ul> <li>Wal-Mart (NYSE:<a href='https://seekingalpha.com/symbol/WMT' title='Walmart Inc.'>WMT</a>) reports comparable sales in the U.S. increased 1.4% in Q1 vs. +1.3% consensus. The mark falls on the top end of the company's own guidance range for a 1.0% to 1.5% gain. Traffic at U.S. stores rose 1.5%, while the average ticket fell 0.1%.</li> <li>Comparable sales at Sam's Club were up 1.6% (ex-fuel) vs. +1.2% consensus.</li> <li>Total U.S. sales rose 2.9% to $75.346B. Operating income +0.9% to $4.269B.</li> <li>Sales were down 3.5% to $27.097B for the Wal-Mart International business. Operating income fell 0.1% to $1.163B.</li> <li>E-commerce growth of 63% was recorded for Wal-Mart U.S. during the quarter.</li> <li>Looking ahead, Wal-Mart sees Q2 U.S. comparables sales growth of 1.5% to 2.5%. The company sets Q2 EPS guidance at $1.00 to $1.08 vs. $1.07 consensus.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3268383-wal-mart-beats-0_04-misses-revenue\" target=\"_blank\">Wal-Mart beats by $0.04, misses on revenue</a> (May 18)</li> <li>WMT <font color='green'>+1.17%</font> premarket to $76.00.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3268391\" data-linked=\"Solid results for Wal-Mart in the U.S.\" data-tweet=\"$WMT - Solid results for Wal-Mart in the U.S. https://seekingalpha.com/news/3268391-solid-results-for-wal-mart-in-u-s?source=tweet\" data-url=\"https://seekingalpha.com/news/3268391-solid-results-for-wal-mart-in-u-s\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3268384\" data-ts=\"1495105472\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GM\" target=\"_blank\">GM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3268384-gm-higher-after-restructuring-moves\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GM higher after restructuring moves</a></h4><ul> <li>General Motors (NYSE:<a href='https://seekingalpha.com/symbol/GM' title='General Motors Company'>GM</a>) <a href=\"https://seekingalpha.com/pr/16836956-general-motors-restructures-international-markets-strengthen-global-business-performance\" target=\"_blank\">announces</a> a series of international restructuring moves which it expects to lead to ~$100M in annual savings.</li> <li>South Africa: The manufacturing plant in Struandale will be sold to Isuzu along with GM's 30% stake in the Isuzu Truck SOuth Africa joint venture.</li> <li>India: The company will stop selling Chevrolet vehicles in the nation.</li> <li>Singapore: The GM International office will be streamlined to help deliver increased organizational efficiencies. The office covers Singapore, Australia, New Zealand, Korea, India and the rest of Southeast Asia.</li><li>Shares of GM are&nbsp;<font color='green'>up 1.54%</font>&nbsp;in premarket trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3268384\" data-linked=\"GM higher after restructuring moves\" data-tweet=\"$GM - GM higher after restructuring moves https://seekingalpha.com/news/3268384-gm-higher-after-restructuring-moves?source=tweet\" data-url=\"https://seekingalpha.com/news/3268384-gm-higher-after-restructuring-moves\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}